Orca1

Data catalog

Regulations.gov documents

About 214K records

More records

Continuing the Regulations.gov documents list, 1000 records per page, after FDA-2023-H-0755-0001.

  1. FDA-2012-S-1144-2665Perrigo - CareOne®- Advanced Eye Health - EPA and DHA are essential fatty acids that help…
  2. FDA-2016-E-1275-0002Letter from U.S. Patent and Trademark Office
  3. FDA-2016-H-0461-0002Complaint
  4. FDA-2024-H-3519-0001Complaint
  5. FDA-2015-H-4725-0001CTP CMP Case re Boyer Mini Market I Inc. d/b/a Boyer Mini Market
  6. FDA-2017-N-1003-0046Request for Participation (ELP) from Medtronic
  7. FDA-2011-S-0932-1693Dee Cee Laboratories, Inc. - #978 Buffered C - Supports Antioxidant Health and Immune…
  8. FDA-2007-N-0083-0008M. Kremzner - Request for Appearance
  9. FDA-2016-E-2463-0005Determination of Regulatory Review Period for Purposes of Patent Extension; NINLARO
  10. FDA-2001-Q-0085-0020Supplement Information (Studies 1, 2, 3) from Rhodia Inc & Quaker Oats Company
  11. FDA-2017-H-6796-0001Complaint
  12. FDA-2019-H-0616-0001Complaint
  13. FDA-2025-H-2257-0001Complaint
  14. FDA-1993-N-0023-0002Neurological Devices; Effective Date of Requirement for Premarket Approval of Cranial…
  15. FDA-2020-V-0767-0003Letter from FDA CDRH to Roumen Lefterov
  16. FDA-2016-M-1165-0002Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval…
  17. FDA-2011-N-0002-0094Workshops: Clinical Trial Requirements, Regulations, Compliance, and Good Clinical…
  18. FDA-2016-N-3120-0443Reference 75 (see abstract) re Request for Hearing from Kremers Urban Pharmaceuticals…
  19. FDA-2022-N-0736-0001NOOH letter from FDA ORA to Gregory Settino_Redacted
  20. FDA-2004-E-0330-0011Patent Term Extension Application - Exhibit B
  21. FDA-2019-H-5288-0001Complaint
  22. FDA-2012-V-0768-0002Acknowledgement Letter to Elev8d LLC
  23. FDA-2010-P-0171-0004Attachment 3 - "Additions/Deletions for Prescription Drug Product List" - [Sun…
  24. FDA-1978-N-0018-0018Interim Response Letter from FDA CDER to Rona
  25. FDA-2003-V-0415-0002HFA-305 to GEKD, Inc.
  26. FDA-1995-N-0054-13712Background Material for NFR 1
  27. FDA-2014-D-0055-0010Reference 17-000 List of References re Voluntary Sodium Reduction Goals: Target Mean and…
  28. FDA-2019-N-3325-0027Reference 2: FDA Draft Guidance for Industry, “Submission of Laboratory Packages by…
  29. FDA-1977-N-0022-0041Reference 108- Twiehaus, M.J., "Control of Anaplasmosis by Feeding An Antibiotic…
  30. FDA-2014-N-0189-36456Request for Extension from William R. Boulter
  31. FDA-2017-H-1854-0001CMP Complaint Issued to Peck Petroleum Corp. d/b/a Arco / Gourmet Espresso Mart
  32. FDA-2006-P-0331-0003Acknowledgment Letter from FDA DMB to Rakoczy Molino Mazzochi Siwik LLP
  33. FDA-2020-D-0957-0152152-[510(k)]-Submissions-for-Chemical-Indicators
  34. FDA-2019-V-4506-0004Variance Approval Letter from FDA CDRH to Kinetic Designs LLC
  35. FDA-1997-S-0039-0732Planetary Ayurvedics - Letter
  36. FDA-2012-N-1037-0065Reference 34 - Centers for Disease Control and Prevention, “Making Healthcare Safer…
  37. FDA-2023-H-4479-0001Complaint
  38. FDA-2015-N-3469-0126Nomination from Outsourcing Facilities Association
  39. FDA-1994-F-0109-0002Environmental Assessment from Sandoz Huningue S.A re FAP4B4423
  40. FDA-2017-N-6730-0001Center for Devices and Radiological Health; Medical Devices and Combination Products…
  41. FDA-2017-H-4098-0001CMP Complaint Issued to Bhavya Corporation d/b/a Pleasure Isle
  42. FDA-1997-N-0041-0025FDA Response to Knoll Pharmaceutical Company - Petition Denial (PDN2)
  43. FDA-2019-N-5900-0030Agency Information Collection Activities; Announcement of Office of Management and Budget…
  44. FDA-2023-E-3305-0003Letter from FDA CDER to U.S. Patent and Trademark Office
  45. FDA-2014-V-1806-0001Variance Application from Salsa Sensation Latin Dance Studio
  46. FDA-2024-H-4056-0001Complaint
  47. FDA-2011-P-0881-0004FDA/CDER to Pharmaceutical Security Institute, Inc. - Petition Denial
  48. FDA-2007-E-0398-0002FDA Center for Drug Evaluation Research to the USPTO - Letter
  49. FDA-2023-F-5500-0002Environmental Assessment Phase 1) Chromium Propionate in Turkey Diets
  50. FDA-2008-P-0473-0001AngioScore, Inc. - Citizen Petition
  51. FDA-2015-V-2869-0002Acknowledgement Letter from FDA DDM to Odyssey Entertainment
  52. FDA-2022-H-2598-0001Complaint
  53. FDA-2019-H-3876-0001Complaint
  54. FDA-2009-S-0608-0088NDI 587 - Androsta-l,4,6-triene-3,17-dione from Proprietary Wellness
  55. FDA-2018-P-1808-0003Attachment 1 Orange Book re Citizen Petition from Lachman Consultant Services, Inc
  56. FDA-2014-N-0189-3299Request for Extension from Anonymous
  57. FDA-2017-N-6189-0650Tobacco Product Standard for Nicotine Level of Combusted Cigarettes; Extension of Comment…
  58. FDA-2016-H-0917-0002Complaint
  59. FDA-2015-H-0062-0001Complaint
  60. FDA-1997-S-0039-1791NBTY, Inc. - Ear Care Formula with Bioflavonoids - Supports Ear Health through Antioxidant…
  61. FDA-2007-P-0405-0004Matrix Laboratories, Inc. - Attachment 2: KALETRA Tablets/Oral Solution Information
  62. FDA-2002-P-0245-0003Final Response from FDA CDER to Lachman Consultant Services, Inc.
  63. FDA-2022-E-0767-0005Determination of Regulatory Review Period for Purposes of Patent Extension; PORTICO…
  64. FDA-1996-N-0270-0308Request for Extension from NRA & APPI
  65. FDA-2010-P-0322-0002Acknowledgement Letter to Amgen Inc.
  66. FDA-2015-S-0024-3484NOW - Ginkgo Biloba 120 mg - Supports Cognitive Function
  67. FDA-1975-N-0012-0052Electronic Correspondence from Ciba to FDA July 21, 2009
  68. FDA-2016-P-3560-0002Acknowledgment Letter from FDA DDM to Orchid Healthcare (A Division of Orchid Pharma Ltd.)
  69. FDA-1994-P-0054-0012FDA Executive Secretariat Response to Robert Cohen - Letter
  70. FDA-2021-V-0161-0002Acknowledgment Letter from FDA DMS to Andrew Shelton
  71. FDA-2013-D-1170-0001Draft Guidance for Industry on Chronic Hepatitis C Virus Infection: Developing…
  72. FDA-2021-S-0024-10782021-001377 - Pharmavite LLC - Nature Made Prenatal Multivitamin Softgel - may help…
  73. FDA-2014-P-0282-0003Memorandum from FDA CDER to Custo Pharm, Inc.
  74. FDA-2004-P-0100-0001Acknowledgment Letter from FDA DMB to City of Arlington Texas
  75. FDA-2015-V-1127-0001Variance Application from Eastside Cannery Casino & Hotel
  76. FDA-2021-S-0024-04282021-000640 New Generation Wellness Inc - Bengal Bites Chewable Tablet - promotes healthy…
  77. FDA-2009-S-0607-1188Perrigo - Welby Calcium - Vitamin D to Help Calcium Absorption
  78. FDA-1998-P-0398-0003Exhibit C - "April 9, 1998 Letter From Duramed Pharmaceuticals to the National Black…
  79. FDA-1989-G-0391-0107Appendix A Revised Environmental Assessment re: Fifth Supplement from Kellogg Company…
  80. FDA-1991-P-0355-0044Reference List from FDA/CFSAN (HFF-414)
  81. FDA-2020-S-0024-12212020-001433 - PYM Health, Inc. - PYM Original Mood Chews - Support for Overwhelm, Anxiety…
  82. FDA-2013-S-0024-0010NBTY Inc Turmeric, Omega 3 and Bromelain supplement Letter
  83. FDA-2017-S-0024-08312017000999 - International Vitamin Corporation - MULTIPLE CLAIMS (6)
  84. FDA-2010-S-0664-0526Country Life - Coenzyme Active B-6 Caps - Energy Production
  85. FDA-2017-S-0023-0051NDI 1002 - Massage Oil from V.A. Worldwide Ltd
  86. FDA-2024-E-3545-0003Letter to U.S. Patent and Trademark Office
  87. FDA-2024-N-5933-0096Kahan 2020
  88. FDA-2006-E-0507-0006FDA/CDER to the USPTO - Letter
  89. FDA-2015-P-0569-0003Exhibits A to F Citizen Petition From Koch Parafinczuk and Wolf, P.A.
  90. FDA-2016-H-1338-0001Complaint
  91. FDA-1977-N-0002-1162Answer Letter from FDA/Office of Legislative Services to Honorable Eldon Rudd, House of…
  92. FDA-2025-P-0434-0002Acknowledgment Letter from FDA DMS to Senores Pharmaceuticals, Inc.
  93. FDA-2011-N-0146-0202Reference 3: FDA Office of Foods and Veterinary Medicine Memorandum to the Division of…
  94. FDA-2024-H-3093-0001Complaint
  95. FDA-1997-S-0006-1657Courtesy letter and related material from CFSAN to Kion, LLC
  96. FDA-2017-V-4655-0003Variance Approval Letter from FDA CDRH to MODLIFESTYLES
  97. FDA-2023-V-1296-0002Acknowledgment Letter from FDA DMS to Chitwood Studios
  98. FDA-2008-D-0096-0044Reference-52-FSIS-Controlling-LM-Retail re Control of Listeria monocytogenes in…
  99. FDA-2018-S-0023-0125NDI 1086 - Lactobacillus Plantarum CJLP55 - Reference List
  100. FDA-2023-H-0253-0001Complaint
  101. FDA-2018-H-3520-0001Complaint
  102. FDA-2010-S-0664-0784NBTY, Inc. - L-Methionine - Support Fat Metabolism
  103. FDA-2009-S-0607-0516Perrigo - equaline B-12 - Supports Nervous System Health
  104. FDA-1986-G-0007-0022Report 12 Maltitiol GRAS Affirmation Petition (Part 2 of 3) re Citizen Petition from Towa…
  105. FDA-2010-P-0188-0009Exhibit M - "FDA Letter to American Pharmaceutical Partners, Inc., re Calcitrol Injection…
  106. FDA-2019-E-1080-0005Determination of Regulatory Review Period for Purposes of Patent Extension; TAVALISSE
  107. FDA-1987-N-0010-0136Background Material
  108. FDA-2011-D-0287-0023Reference 76 - "Federal Joint Subcommittee on Aquaculture, April 2007, Guide to Drug…
  109. FDA-2006-P-0535-0004Acknowledgment Letter from FDA DMB to Olsson, Frank and Weeda, P.C.
  110. FDA-2016-V-1379-0002Acknowledgement Letter from FDA DDM to Killer Audio
  111. FDA-2016-P-0645-000846. FDA-2012-P-0895-0015 FR re Request FDA uniformly apply its standards for permitting a…
  112. FDA-2016-H-4231-0001Complaint
  113. FDA-2002-N-0265-0038Smith & Nephew, Inc. - Electronic Request for Appearance
  114. FDA-2012-S-1144-0470NBTY, Inc. - Papaya Enzyme supplements under the Radiance label - As the perfect "after…
  115. FDA-2012-S-1144-2130Cott Beverages, Inc. - Kroger B-Vitamins and Amino Acid Dietary Supplement (Extra Strength…
  116. FDA-2004-N-0188-0095Reference 29 vCJD Key Facts re Use of Materials Derived From Cattle in Human Food and…
  117. FDA-1997-S-0039-1775Perrigo Company of South Carolina - Dollar General®- Hair, Skin & Nails - Antioxidants may…
  118. FDA-2000-P-1400-0010Attachment 9 September 21 1999 Press Release re Citizen Petition from Genelabs…
  119. FDA-2025-N-1114-0001NOOH Letter from FDA OII to Jason Oppenheimer
  120. FDA-2014-E-2326-0008Letter from FDA CDER to the U.S. Patent and Trademark Office
  121. FDA-2020-N-2029-0310References 7 RE Covis Pharma GmbH’s Briefing Materials In Response To The Center for Drug…
  122. FDA-2018-V-3808-0004Variance Amendment Request from Clay Paky S.p.A to FDA CDRH
  123. FDA-2016-S-0024-1049Lief Organics - C-Load - Vitamin C and all other ingredients
  124. FDA-2016-N-0124-0384Lonza Inc. A Pivotal Maximal Use Study to Measure the Systemic Absorption of Benzalkonium…
  125. FDA-2004-N-0048-0001Agency Information Collection Activities; Proposed Collection; Comment Request; Medical…
  126. FDA-2006-P-0136-0005Background Materials re: Citizen Petition from Vintage Pharmaceuticals, LLC - Search…
  127. FDA-2009-S-0607-0280Perrigo - Multiple claims - 3
  128. FDA-1980-N-0049-0120Letter from David Panzera to FDA/DDM re: Electronic Comment from Mr. David Panzera
  129. FDA-2009-S-0607-1685New Chapter, Inc - Probiotic Cleanse - To help promote bowel detoxification and overall…
  130. FDA-2020-S-0024-0551SFC2020-000682 Genexa- Genexa Kids' Honey Cough Syrup- Support immunity-
  131. FDA-2001-D-0129-0010Declaration of Fritz L. Lorscheider, Ph.D. (Ref: FDA-2001-D-0129-0008)
  132. FDA-2024-H-5364-0001Complaint
  133. FDA-2016-H-0692-0001CTP CMP Case re Speedway LLC d/b/a Speedway 03473
  134. FDA-2004-V-0362-0001HFA-305 to G and G Sound and Lighting
  135. FDA-1997-S-0039-1772Perrigo Company of South Carolina - Vitasmart® - D - Bone Health
  136. FDA-2010-D-0503-0001Draft Guidance for Industry: Investigational New Drug Applications; Determining Whether…
  137. FDA-2019-N-3065-0606Reference 11 - Required Cigarette Health Warnings, 2020
  138. FDA-2019-D-1650-0001Magnetic Resonance Coil— Performance Criteria for Safety and Performance Based Pathway…
  139. FDA-2017-D-4713-0002Ultrafiltered Milk in the Production of Standardized Cheeses and Related Cheese Products…
  140. FDA-2024-H-1443-0001Complaint
  141. FDA-2024-S-0024-01512024-000658 - ATP CO. LTD. - Beme WELLNESS Be Sharp- Support Mental Wellness
  142. FDA-2007-D-0369-2308PSG_219015 - Draft Guidance on Minocycline Hydrochloride
  143. FDA-1996-G-0303-0009List of References re: GRAS Affirmation Petition from FMC Corporation
  144. FDA-2016-H-1959-0001Complaint
  145. FDA-2011-N-0922-0544Reference 6. FRIA - Banfield State_of_Pet_Health_2012 re Current Good Manufacturing…
  146. FDA-2013-E-0782-0001Talon Therapeutics, Inc. (on behalf of Kenyon & Kenyon, LLP) - Patent Extension…
  147. FDA-2004-E-0269-0008U.S. Patent & Trademark Office
  148. FDA-2010-N-0180-0002Agency Information Collection Activities; Proposals, Submissions, and Approvals: Adoption…
  149. FDA-1997-S-0039-1104Perrigo Company of South Carolina - Good Health-Magnesium - Bone Health
  150. FDA-2025-H-1205-0001Complaint
  151. FDA-2010-S-0664-0505Reliance Vitamin Company, Inc. - Strawberry Banana Flax Fusion - Heart Healthy
  152. FDA-2016-H-0194-0002Complaint
  153. FDA-2010-S-0664-2228Perrigo - H-E-B Dairy Digestive - Prevnet Gas, Bloating and Diarrhea
  154. FDA-2006-E-0263-0007Scios Inc. - Patent Term Extension Application
  155. FDA-2007-P-0183-0007Acknowledgement Letter - Purdue Pharma L.P.
  156. FDA-2010-S-0665-0188NDI 668, EstroG-100 from Sunbio Corporation
  157. FDA-2010-D-0194-0018Agency Information Collection Activities; Proposals, Submissions, and Approvals: Draft…
  158. FDA-2024-H-4434-0001Complaint
  159. FDA-1997-S-0006-0153HFS-800 to New Chapter Inc
  160. FDA-2025-H-1209-0001Complaint
  161. FDA-2018-N-4626-0160Nomination from Wedgewood Pharmacy
  162. FDA-2014-N-0189-4720Request for Extension from Anonymous
  163. FDA-2019-E-3294-0009Notice of Final Determination and Requirement for Election Letter from U.S. Patent and…
  164. FDA-2005-P-0375-0002Acknowledgement Letter from FDA DDM to Consumers for Dental Choice
  165. FDA-2014-S-0024-0240Waterpure, Inc (Fun Greens) - Letter
  166. FDA-2017-H-5345-0001Complaint
  167. FDA-2018-H-3701-0001Complaint
  168. FDA-2023-E-1620-0002Patent Extension Application from Goodwin Procter LLP (on behalf of Agios Pharmaceuticals…
  169. FDA-2012-N-1239-0001Dental Devices: Reclassification of Temporary Mandibular Condyle Prosthesis
  170. FDA-2023-H-0586-0001Complaint
  171. FDA-2012-P-0272-0001Actavis Inc. - Citizen Petition
  172. FDA-1996-P-0030-0001Memorandum of Telephone Conversation between Hyman, Phelps & McNamara, P.C. and FDA
  173. FDA-2024-S-0024-04692024-001292 - Luminary Vitamins LLC - Luminary Vitamins, Form- support your body during…
  174. FDA-2013-V-0864-0001Laser Safety Services (Yuma Crossing National Heritage Area Corporation) - Application for…
  175. FDA-1980-N-0038-0033Request for Hearing from The Upjohn Company
  176. FDA-2025-S-0024-15482025-001669 - Schwabe North America Inc - MULTIPLE CLAIMS (3)
  177. FDA-2020-V-0348-0003Letter from FDA CDRH to Smiths Auto Service Inc
  178. FDA-2015-S-0024-0079NBTY Inc - Vitamin E supplements - Supports healthy heart and immune system
  179. FDA-2017-H-0225-0001Complaint from FDA CTP to RMJO Enterprises, Inc. d/b/a Exxon Food Mart
  180. FDA-2006-N-0304-0038Graceway Pharmaceuticals, LLC - Supplement Comment re FDA-2006-N-0304-0032
  181. FDA-2009-P-0587-0009Tab 13 - Wolf T. et al, "Folic Acid Supplementation for the Prevention of Neural Tube…
  182. FDA-2017-H-6023-0001Complaint
  183. FDA-2016-H-0293-0001CTP CMP Case re 8 Till Late 16 South, Inc. d/b/a 8 Till Late 16 / Shell
  184. FDA-1976-N-0027-0081Tab 12 81N-0022, Vol 5, CP 5 without attachments re Citizen Petition from Thompson Medical…
  185. FDA-2011-S-0932-2221NOW Foods - Herbal Pause with EstroG-100 - Natural Menopause Relief
  186. FDA-2014-N-1051-0686685 7694105 Survey Subject R3027_Redacted
  187. FDA-1979-P-0020-0005Variance Approval Letter from FDA CDRH to Eastern Florida State College Planetarium
  188. FDA-2024-V-5745-0002Variance Acknowledgment Letter from FDA DMB to Self
  189. FDA-2023-N-2177-7011Reference 161 - FDA Response to Request for Comment Period Extension
  190. FDA-2023-N-3902-0432Comment from Samantha Perry
  191. FDA-1977-N-0014-0960Answer Letter from FDA to Comment from The Honorable Larry Winn, Jr., United States House…
  192. FDA-2021-S-0024-14332021-001564 - Swanson Health Products 11658148874- Swanson Health Products, Gummies…
  193. FDA-2000-N-0109-0060Corrected May 6, 2003 Transcript
  194. FDA-2007-N-0198-0002FDA/CFSAN/ONLDS
  195. FDA-2024-H-1578-0001Complaint
  196. FDA-2014-H-1864-0001Complaint
  197. FDA-1993-G-0218-0494Table D-1: Part D: MRCA Report for Oat Fiber(continued) - As Consumed Levels of Oat Fiber…
  198. FDA-2007-N-0442-0001FDA
  199. FDA-2015-H-3652-0001CTP CMP Case re Lynn Pederson d/b/a Gate City General
  200. FDA-2026-P-0056-0001Suitability Petition from Regulatory Compliance Solutions LLC (on behalf of Flea Assassin…
  201. FDA-1997-S-0039-2275Perrigo Company of South Carolina - Meijer Calcium Citrate+ - Bone Health
  202. FDA-2023-V-5238-0003Variance Approval Letter from FDA CDRH to Seiko Epson Corporation
  203. FDA-2025-H-3892-0001Complaint
  204. FDA-2023-S-0023-0040NDI 1287 - Golden Caps from Nourished Vines, LLC
  205. FDA-1990-S-0006-0237HFD-7 - Memo - Ted Sherwood
  206. FDA-2015-N-0101-0910Reference 39-67 - FDA-1975-N-0012-0258 --- CP16 re Safety and Effectiveness of Health Care…
  207. FDA-2023-N-3902-0164Reference 136 - J Samuels, DOJ, letter re Banned Devices; Proposal To Ban Electrical…
  208. FDA-2024-H-3547-0001Complaint
  209. FDA-2016-H-3469-0001Complaint
  210. FDA-1987-P-0074-0005Canned Pacific Salmon Deviating From Identity Standard; Amendment of Temporary Marketing…
  211. FDA-2024-V-1793-0003Variance Approval Letter from FDA CDRH to Audio Video Export, LLC
  212. FDA-2017-H-2127-0001CMP Complaint Issued to Fresh Start Convenience Stores, Inc. d/b/a Fresh Start
  213. FDA-2013-V-1535-0002Acknowledgement Letter to Danni Productions LLC
  214. FDA-2010-S-0664-0174Vitacost.com, Inc. - NSI Acetyl L-Carnitine HCI & Acetyl L-Carnitine Arginate - Promote…
  215. FDA-2014-N-2244-0107Reference 99 eXtension_2014_Manure Pathogens and Microbial Byproducts re Draft…
  216. FDA-2019-S-0024-06962019002523 - 1159814 B.C. Ltd. - Yuva Caps - Supports cells by reducing the the oxidative…
  217. FDA-2005-V-0145-0004FDA/CDRH to Sapphire Nightclub - Letter
  218. FDA-2013-S-0024-0730Herbalife - Garden 7 Dietary Supplement (F1707-00) - Helps nourish cells and organs so…
  219. FDA-2020-P-1597-0013Appendix 13 RE: Petition for Administrative Stay of Action from Informed Consent Action…
  220. FDA-1977-N-0224-0137Answer Letter from FDA to Comment from The Honorable Paul Laxalt, United States Senate
  221. FDA-2023-N-2177-6885Reference 35 - “It Has Come to Our Attention” Letter to Texas Children’s Hospital and…
  222. FDA-2001-P-0123-0037Petition Response References
  223. FDA-2014-N-0189-5477Request for Extension from Anonymous
  224. FDA-2023-H-5646-0001Complaint
  225. FDA-2004-S-0571-0060NDI 190 - Creatine Ethyl Ester - Original NDI Notification
  226. FDA-2015-S-0024-3397Munuka Health New Zealand Ltd - Multiple claims - 2
  227. FDA-2015-H-0257-0001Complaint
  228. FDA-2021-V-0592-0002Acknowledgment Letter from FDA DMS to Spacebar Arcade
  229. FDA-2017-H-3294-0001CMP Complaint Issued to BG Singh LLC d/b/a Citgo Mart
  230. FDA-2010-S-0664-0366Perrigo - CVS Pharmacy Teen Multi-Vitamin - Support a Healthy Immune System
  231. FDA-2011-V-0764-0001Barry Willems - Application for Variance
  232. FDA-2016-H-0326-0002Complaint
  233. FDA-2016-H-0218-0001CTP CMP Case re Saleh and Nizar Corp. d/b/a Good To Go Food Mart and Fresh Deli
  234. FDA-2024-E-0135-0004Letter to U. S. Patent and Trademark Office
  235. FDA-2025-S-0024-05672025-000654 - Pharmavite LLC - Nature Made Focus Boost Capsules - help reduce mental…
  236. FDA-2013-S-0023-0001NDI 775 Guanidinoacetic acid from AlzChem AG
  237. FDA-2022-S-0024-06712022-000685 - MindBodyGreen LLC - brain guard - enhanced learning speed and promotes brain…
  238. FDA-2020-N-2319-0005Request for Extension from Society of Quality Assurance (SQA)
  239. FDA-1980-N-0038-0356Order from FDA
  240. FDA-2020-M-2248-0002Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval…
  241. FDA-2014-P-1483-0003Withdrawal of Petition from Upsher-Smith Laboratories, Inc.
  242. FDA-2014-P-0328-0004Citizens Petition Approval Letter to Robert Dormer and Gordon Johnston
  243. FDA-1997-N-0010-0007Foundation for the Accreditation of Cellular Therapy (FACT) - Supplement(2)
  244. FDA-2022-E-2260-0001Letter from U.S. Patent and Trademark Office
  245. FDA-2023-H-3182-0001Complaint
  246. FDA-2015-V-1599-0002Acknowledgement Letter From FDA DDM to Gregory Richards
  247. FDA-2007-P-0183-0004Purdue Pharma L.P., & Rhodes Technologies - Letter
  248. FDA-2017-N-0763-0217215 Reference_214 Chan_2007_Isoflavone intake in persons at high risk of cardiovascular…
  249. FDA-2019-N-3065-0186Reference 184 - Women and Smoking _A Report of the Surgeon General, 2001 re Tobacco…
  250. FDA-1991-N-0365-0194Answer from FDA DDM to Honorable John E. Ware Re: Comment from Samuel F. Scheidy, M.D.
  251. FDA-2015-V-2798-0002Acknowledgement Letter from FDA DDM to Visceral Sight and Sound
  252. FDA-2017-H-5151-0001Complaint
  253. FDA-2015-P-1103-0003Interim Response Letter from FDA CDER to Hyman, Phelps & McNamara, P.C.
  254. FDA-2019-N-4203-0034Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Change of…
  255. FDA-2019-H-0818-0001Complaint
  256. FDA-2015-S-0024-2154NBTY, Inc. - Niacinamide - Cardiovascular support
  257. FDA-1987-P-0132-0004Approval of Citizen Petition from FDA to Barr Laboratories, Inc.
  258. FDA-2020-V-1574-0001Variance Approval Letter from FDA CDRH to Ryan Rojany
  259. FDA-1993-G-0221-0026Revised Environmental Assessment from Agent for Foreign Domestic Chemicals Corporation
  260. FDA-2010-S-0664-1509North American Pharmacal, Inc. - D'Adamo Personalized Nutrition®, CIearCal - Unique source…
  261. FDA-2018-H-4040-0001Complaint
  262. FDA-1975-N-0016-0024Acknowledgement Letter from FDA/DDM to Xttrium Laboratories, Inc. (Kleinfeld, Kaplan &…
  263. FDA-2022-H-0957-0001Complaint
  264. FDA-2024-H-4005-0001Complaint
  265. FDA-2020-P-1601-0020Appendix 17 RE: Citizen Petition from Informed Consent Action Network
  266. FDA-2017-D-6530-0001Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of…
  267. FDA-2017-P-5787-0088Reference 86 Ko_CDER Medical Review_NDA 20-788_P4 (Dec-1997) re Citizen Petition Post…
  268. FDA-2004-P-0339-0017References for Citizen Peition Response
  269. FDA-2022-H-1521-0001Complaint
  270. FDA-2021-S-0024-14112021-3236 Waterpure dba Purity Products - MULTIPLE CLAIMS (6)
  271. FDA-2011-N-0921-19147Reference 2 Produce Ag Water compliance extension PRIA Sept 2017 re Standards for the…
  272. FDA-2007-N-0037-0001Agency Information Collection Activities; Proposed Collection; Comment Request; Animal…
  273. FDA-2011-S-0932-2471Mission Endurance, LLC - Mission Endurance, SciTri Endurance Sports & Recovery Drink…
  274. FDA-2023-H-4618-0001Complaint
  275. FDA-2015-N-3469-0156Nomination from Triangle Compounding Pharmacy, Inc.
  276. FDA-2017-S-0024-0040The Nature's Bounty Co 9, Sundown Naturals® Kids Complete Multivitamin Gummies featuring…
  277. FDA-2025-P-2547-0006Attachment 4 - FDA Grant Response Letter - FDA-2020-P-0624
  278. FDA-2000-D-0075-0002Agency Information Collection Activities; Submission for Office of Management and Budget…
  279. FDA-2024-V-3146-0001Variance Application from Kelly Ganley
  280. FDA-2004-P-0223-0005FDA - Notice of Meeting
  281. FDA-2004-N-0379-0002Agency Information Collection Activities; Submission for Office of Management and Budget…
  282. FDA-2004-N-0451-0017Food and Drug Administration Modernization Act of 1997: Modifications to the List of…
  283. FDA-2007-E-0398-0012Patent Term Extension Application [ FDA-2007-E-0398-0004] - Exhibit F
  284. FDA-2011-S-0932-2884NBTY, Inc. - Giant Eagle Vitamin C 1000 mg Supplements - Helps Support Healthy Immune…
  285. FDA-1996-N-0028-0075Pre_FDMS - OMB Review 10/25/2005
  286. FDA-2012-D-0322-0039Ref 11. Analytical Results For Arsenic Lead Cadmium MercuryFood Intended For Babies And…
  287. FDA-2011-S-0932-2679NBTY, Inc. - Coenzyme Q-10 - Heart Support
  288. FDA-1997-S-0006-0210FDA/CFSAN to Beulah Land Corporation
  289. FDA-2025-V-2918-0002Variance Acknowledgment Letter from FDA DMB to Hershey Entertainment & Resorts
  290. FDA-2025-H-0632-0001Complaint
  291. FDA-2024-N-2177-0002Agency Information Collection Activities; Submission for Office of Management and Budget…
  292. FDA-2025-S-0024-10982025-001184 - Healthy Decisions Inc - Pep - Pep reduces triglycerides in rodents fed high…
  293. FDA-2024-V-2156-0002Acknowledgment Letter from FDA DMS to Kyle Beatham
  294. FDA-2008-P-0242-0002National Toxic Encephalopathy Foundation - Citizen Petition
  295. FDA-1977-N-0018-0005Establishment of A Monograph for OTC Internal Analgesic, Antipyretic and Antirheumatic…
  296. FDA-2012-S-1144-1346NBTY, Inc. - B-12 - Promotes energy metabolism & nervous system health
  297. FDA-2008-P-0296-0005Enclosure 11 - Top 200 Brand Drugs By Units In 2007
  298. FDA-2023-H-5182-0001Complaint
  299. FDA-2008-N-0043-0008Memorandum of Agreement Between the Food and Drug Administration, the National Cancer…
  300. FDA-2013-D-0880-0054Reference 5.6 CDC Eat right re Frequently Asked Questions About Medical Foods; Second…
  301. FDA-2006-P-0459-0002FDA/DDMB to Beckloff Associates
  302. FDA-2018-V-0238-0004Variance Approval from FDA CDRH to Liberty Science Center
  303. FDA-2025-E-0489-0004Letter from U.S. Patent and Trademark Office to FDA CDER
  304. FDA-2022-H-1383-0001Complaint
  305. FDA-2018-P-3325-0011Tab 9_Pfizer Report 1 re Citizen Petition from Pfizer Inc
  306. FDA-2014-H-0423-0001Complaint
  307. FDA-2024-V-2656-0001Variance Application from Robert Talley
  308. FDA-2024-S-0024-12822024-002172 - DOVITA NUTRITION HEALTH LLC- AIDEVI NAD+ ULTRA BOOSTER 15000 CAPSULE…
  309. FDA-2003-D-0203-0003Guidance
  310. FDA-2019-P-0538-0017Exhibit 014 - 62 Fed_ Reg_ 43,535 (Aug_ 14, 1997)Re: Citizen Petition from K&L Gates LLP…
  311. FDA-2025-H-5906-0001Complaint
  312. FDA-1976-N-0476-0533Memorandum of Telephone Conversation between Joe DiNetta (Hoechst-Roussel) and Dr. P. D…
  313. FDA-1995-P-0016-0021Background Material in 94P-0390
  314. FDA-2008-N-0120-0009Talecris Biotherapeutics, Inc. - [Re: FDA-2008-N-0120-0011]
  315. FDA-2016-S-0024-2297Country Life LLC - Country Life/ /Bio-Rutin Complex - Supports antioxidant activity
  316. FDA-2023-H-2999-0001Complaint
  317. FDA-2013-V-1130-0001Made Up LTD - Application for Variance
  318. FDA-2015-N-3534-0465Nomination from Anonymous
  319. FDA-2018-P-4549-0001Citizen Petition from Unichem Pharmaceuticals (USA), Inc.
  320. FDA-2019-H-1121-0001Complaint
  321. FDA-2014-S-0024-1028Perrigo Company (H E B - Complete) - Letter
  322. FDA-2017-H-4368-0001CMP Complaint Issued to Sav On Gas, Inc. d/b/a Sav-On Gas
  323. FDA-2010-S-0664-0062The Herban Alchemist - Peaceful Heart Herbal Supplement - Combination for Emotional and…
  324. FDA-2018-P-2362-0006Withdrawal from Lachman Consultant Services, Inc.
  325. FDA-2025-N-1160-0001Medical Devices; Immunology and Microbiology Devices; Classification of the Zika Virus…
  326. FDA-2013-S-0024-0589Perrigo Company (Smart sense - Magnesium) - Letter
  327. FDA-1990-G-0246-0226Attachment/Annex 8.2B - Determination of Formaldehyde In Various Isomalt Samples re…
  328. FDA-2011-S-0932-2281Vitacost.com, Inc. - Vitacost Triple Fiber - Fiber promotes healthy digestion
  329. FDA-2019-V-4858-0002Acknowledgment Letter from FDA DMS to Electric Polar Bear, LLC
  330. FDA-2009-S-0608-0074Letter from FDA/CFSAN to Shannon Minerals Ltd. re NDI 304 - Extract of Garcinia Cambogia…
  331. FDA-2025-H-4730-0001Complaint
  332. FDA-2017-S-0024-04242017-5059 Daiwa Health Development - Daiwa Super Krill Oil - Promotes cardiovascular and…
  333. FDA-2011-N-0121-0008Further Amendments to General Regulations of the FDA to Incorporate Tobacco Products…
  334. FDA-2018-H-4118-0001Complaint
  335. FDA-2022-D-0465-004946 NAT of blood donors for transfusiontransmitted infectious diseases 2000
  336. FDA-1994-G-0060-0001Notice of Filing from Nabisco, Inc.; Filing of Petition of Affirmation of GRAS Status
  337. FDA-2025-P-4911-0001Suitability Petition from Laboflex, Inc.
  338. FDA-1995-S-0036-0215Public Disclosure from Boston Children's Hospital
  339. FDA-2017-S-0024-03592017-3910 Wellnext- MULTIPLE CLAIMS (2)
  340. FDA-2020-E-1820-0002Patent Extension Application from Foley & Lardner LLP (on behalf of Daiichi Sankyo…
  341. FDA-2010-S-0664-0031Perrigo - Meijer Glucosamine Sulfate - Maintain Healthy Joints and Cartilage
  342. FDA-2015-S-0024-2229Perrigo - CVS/pharmacy® - Calcium Plus Minerals & Vitamin D3 Minis - CVS/pharmacy® Calcium…
  343. FDA-2019-E-1061-0002Letter from FDA CDER to U.S. Patent and Trademark Office
  344. FDA-2012-S-1144-1955Chicago Center for Anti-Aging - Natural Joint Support with Glucosamine & Chondroitin
  345. FDA-2007-P-0109-0005FDA Response to People for the Ethical Treatment of Animals (PETA) - Letter
  346. FDA-2023-H-1563-0001Complaint
  347. FDA-2009-P-0423-0010Reference 3 - "Notification of Noninfringement of Patent No. 5,238,944" - [Graceway…
  348. FDA-2015-H-5042-0001CTP CMP Case re Durla J, Inc. d/b/a Boulevard Grocery
  349. FDA-2014-N-0189-83112Reference 208 The Adolescent Brain and Age Related Behavioral Manifestations re Deeming…
  350. FDA-2020-N-2029-0333July 1 2022 Letter to CDER and Covis RE Proposal to Withdraw Marketing Approval; Notice of…
  351. FDA-1997-S-0006-0821HFS-810 to J. R. Carlson Laboratories Inc. - Letter - Let 510
  352. FDA-2024-H-5816-0001Complaint
  353. FDA-2006-P-0460-0001Acknowledgement Letter to Banner & Witcoff, Ltd.
  354. FDA-2014-N-1051-0729728 7694105 Survey Subject R4038_Redacted
  355. FDA-1999-N-0134-0029Risk Assessment
  356. FDA-2021-V-0809-0002Acknowledgment Letter from FDA DMS to Idigital
  357. FDA-2009-S-0607-1399Perrigo - Dolgencorp, LLC DG Health One Daily - Promote Strong Bones and Breast Health
  358. FDA-2021-S-0024-05292021-000750 Natrol LLC - Natrol Relax + Ultimate Calm - Helps reduce occasional stress…
  359. FDA-1977-P-0017-0007Internal Memorandum from Margaret Gilhooley, FDA/Office of the General Council to FDA/DDM…
  360. FDA-1993-P-0038-0002Citizen Petition from Bumble Bee Seafoods, Inc. (Olson, Frank and Weeda, P. C.)
  361. FDA-2016-S-0024-0474Balance Factor, Inc - Ultra Omega 3 Fish Oil 60 Softgels, a dietary supplement - Supports…
  362. FDA-2023-H-3946-0001Complaint
  363. FDA-2012-E-1244-0001The Henry M. Jackson Foundation for the Advancement of Military Meicine (Finnegan…
  364. FDA-2023-S-0024-02252023-000248 - Lemme Inc. - Lemme Purr - Supports vaginal and digestive health
  365. FDA-2004-P-0022-0002Acknowledgment Letter from FDA/DMB to Cardinal Health
  366. FDA-2014-N-1051-0224222 7694105 Diary Subject R4064_Redacted
  367. FDA-2015-S-0024-0689Perrigo Company - Smart sense® - CENTURY ADULT - Heart Health
  368. FDA-2010-S-0665-0139Reference 26 re NDI 649, Pine Tree Phytosterols from Arboris, LLC
  369. FDA-1986-M-0029-0002Tab B: Approval Letter from FDA CDRH to W. L. Gore & Associates, Inc. re: W. L. Gore &…
  370. FDA-2018-S-0024-02632018001432 - Jarrow Formulas, Inc - Kirkland Signature Extra Strength Glucosamine HCl with…
  371. FDA-2024-P-5469-0001Citizen Petition from Novitium Pharma, LLC
  372. FDA-2024-P-5963-0003Attachment 1- Orange Book Listing RLD Adcirca
  373. FDA-2009-S-0607-1667Amerifit. Inc. - Estroven Energy Dietary Supplement - Reduces hot flashes and night sweats
  374. FDA-2010-S-0664-2291Perrigo - H-E-B Complete - Energy Metabolism
  375. FDA-2025-S-0024-04722025-000557 - Himalaya Wellness USA Ltd. - Himalaya Since 1930 - Extra Strength Organic…
  376. FDA-2015-E-4674-0007Determination of Regulatory Review Period for Purposes of Patent Extension; ESBRIET
  377. FDA-2014-H-0744-0001Complaint
  378. FDA-2022-P-2163-0003Interim Response Letter from FDA CDER to Patricia A. Zarzycki
  379. FDA-2011-V-0485-0002Acknowledgement Letter to Sound Stage Systems
  380. FDA-2011-S-0932-0120Letter from NBTY, Inc.
  381. FDA-2013-N-0001-0115Ophthalmic Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
  382. FDA-2023-V-2750-0002Acknowledgment Letter from FDA DMS to Kate Swan LLC
  383. FDA-2012-S-1144-2351Natural Infinity, LLC - Dreamcalm - Natural Sleep Support
  384. FDA-2024-H-5482-0001Complaint
  385. FDA-2016-N-3120-0401Reference 33 FDA Draft Guidance re Request for Hearing from Kremers Urban Pharmaceuticals…
  386. FDA-2023-H-2739-0001Complaint
  387. FDA-2011-N-0921-18966QAR _Reference 141_Lowell-2010-Safe and Sustainable CoManaging for Food Safety and…
  388. FDA-2024-H-3108-0001Complaint
  389. FDA-2025-H-3006-0001Complaint
  390. FDA-2019-H-1056-0001Complaint
  391. FDA-2018-D-4534-0013Reducing Microbial Food Safety Hazards in the Production of Seed for Sprouting; Guidance…
  392. FDA-2018-H-0179-0001Complaint
  393. FDA-2016-H-4294-0001Complaint
  394. FDA-1978-N-0018-0462Letter from FDA/CDER to The Cosmetic, Toiletry and Fragrance Association
  395. FDA-2024-H-0810-0001Complaint
  396. FDA-2019-H-3959-0001Complaint
  397. FDA-2010-S-0664-2285Perrigo - H-E-B Complete - Support Prostate and Colon Health
  398. FDA-2014-P-0772-0004Amendment from Piedmont Animal Health
  399. FDA-2019-S-0024-01072019002075-Lang Pharma Nutrition- CVS Once Daily Complete Prenatal with DHA & Folic Acid…
  400. FDA-2017-H-6774-0001Complaint
  401. FDA-2011-N-0197-0001Criteria Used to Order Administrative Detention of Food for Human or Animal Consumption
  402. FDA-2009-S-0607-0627McLind Corporation - Lindberg Resveratrol - Provides Antioxidant and Cardiovascular…
  403. FDA-2025-S-0024-11302025-001221 - Healthy Decisions Inc - EWel - Helps support normal pelvic and abdominal…
  404. FDA-2018-H-0335-0001Complaint
  405. FDA-2023-H-4486-0001Complaint
  406. FDA-2017-H-1905-0001CMP Complaint Issued to C and L Mini Market 2 LLC d/b/a C and L Mini Market 2
  407. FDA-1991-P-0009-0001MAYONNAISE; PROPOSED AMENDMENT OF THE STANDARD OF IDENTITY
  408. FDA-2019-S-0024-10522019-4615 Church & Dwight Co. Inc.- MULTIPLE CLAIMS (8)
  409. FDA-2022-H-2334-0001Complaint
  410. FDA-2022-H-0845-0001Complaint
  411. FDA-2000-N-0140-0002Letter from DHHS Philadelphia District to Dave Reed
  412. FDA-2016-H-1625-0001Complaint
  413. FDA-2017-H-2064-0001CMP Complaint Issued to Mira-Deli Corporation d/b/a Panaderia Mira-Deli
  414. FDA-1997-S-0039-1295Bayer HealthCare Consumer Care - Citracal Plus - With more Vitamin D for unsurpassed…
  415. FDA-2013-N-0639-0003Turtles Intrastate and Interstate Requirements
  416. FDA-2024-V-2076-0001Variance Application from Heyframes
  417. FDA-2004-N-0317-0001Schering Corp. et al.; Withdrawal of Approval of 92 New Drug Applications and 49…
  418. FDA-2017-H-5258-0001Complaint
  419. FDA-2010-P-0639-0002Attachment 2 - "Full Prescribing Information Taxotere Labeling Version (Track Changes)"…
  420. FDA-2002-N-0275-0001Agency Information Collection Activities; Proposed Collection; Comment Request; Medical…
  421. FDA-2018-S-0024-08212018001853- J.R. Carlson Laboratories -MULTIPLE CLAIMS (2)
  422. FDA-2017-H-5980-0001Complaint
  423. FDA-2009-P-0663-0003Withdrawal Letter from PharmaForce, Inc.
  424. FDA-2019-P-0777-0009Attachment G NDC Average Daily Servings of Dairy Foods by Ethnicity and Age Group (NHANES…
  425. FDA-1980-N-0272-0006Reference 5: Corn Refiners Association. 1976. Page 20 and 25 in Nutritive Sweeteners from…
  426. FDA-2015-H-4988-0001CTP CMP Case re Corktown Fuels, Inc. d/b/a Marathon / Subway
  427. FDA-2012-S-1144-2030Waterpure, Inc. - Nuvaprin HD - Supports a Healthy Vein Appearance
  428. FDA-2021-S-0024-12762021-1041Tomahawk Nutra LLC - Battle Acid, Mortar - support Strength, pump intensity…
  429. FDA-2022-H-2661-0001Complaint
  430. FDA-2019-H-4786-0001Complaint
  431. FDA-2007-P-0185-0004FDA/CDER to Lupin Pharmaceuticals, Inc. - Petition Approval
  432. FDA-1994-G-0160-0031Letter from Keller and Heckman (Soya Oligo Japan Inc) to FDA CFSAN
  433. FDA-2003-N-0049-0025FDA
  434. FDA-2023-H-1612-0001Complaint
  435. FDA-1999-D-2955-0005Guidance for Industry; Availability: Impurities; Residual Solvents in New Veterinary…
  436. FDA-2015-D-3399-0019Recommendations for Microbial Vectors Used for Gene Therapy; Guidance for Industry…
  437. FDA-2015-S-0024-0634NBTY, Inc. - Electrolyte Gummies - Replenish essential electrolytes during exercise
  438. FDA-2004-P-0467-0006Memorandum from FDA CFSAN
  439. FDA-2005-N-0344-0001Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic…
  440. FDA-2010-P-0628-0005Attachment II - "Federal Register/ Vol. 68, No. 178/ Monday, September 15, 2003/Notice"…
  441. FDA-1985-P-0026-0004COPY- Cheeses; Proposal To Permit Expanded' Use of Antimycotics on Exterior of Bulk…
  442. FDA-2015-S-0024-0460Awareness Corporation - Boost Tea - Helps to control appetite &
  443. FDA-1998-N-0288-0006Answer from FDA CFSAN to Chemicals Manufacturers Association
  444. FDA-2005-N-0295-0007FDA/CFSAN (SBradbard) - "Consumer Studies Research Overview" - [Assessing Consumer…
  445. FDA-2015-N-0101-1288Attachment 8 Techni-Care vs Mycobacterium Bovis TMC re: Comment from Care-Tech…
  446. FDA-1987-N-0010-0153Background Material
  447. FDA-2006-P-0446-0002Acknowledgment Letter from FDA DMB to Lachman Consultant Services, Inc.
  448. FDA-2025-H-6977-0001Complaint
  449. FDA-2022-V-0245-0003Variance Approval Letter from FDA CDRH to Carlos Leyva
  450. FDA-2020-H-0999-0001Complaint
  451. FDA-2007-D-0369-0915PSG_215833 Draft Guidance on Lutetium Lu-177 Vipivotide Tetraxetan
  452. FDA-1986-G-0286-0035Letter from FDA/HFS-217 to Jane Heimlich
  453. FDA-2007-E-0102-0014Patent Term Extension Application - Attachment H
  454. FDA-2009-S-0607-1226Perrigo - Leader Dairy Digestive Supplement - Relieves Gas, Cramps, Bloating or Diarrhea…
  455. FDA-1997-S-0006-0280FDA to Market America, Inc.
  456. FDA-2014-S-0024-0680Perrigo Company (Walgreens Finest Nutrition - Omega 7) - Letter
  457. FDA-2020-S-0023-0040NDI 1146 -Microchloropsis gaditana - Original NDI Notification
  458. FDA-2021-V-0224-0002Acknowledgment Letter from FDA DMS to Chad Calvert
  459. FDA-2019-S-0024-06112019-2991 HVL LLC d/b/a Douglas Laboratories - Keto Metabolic - Supports Cognition, Weight…
  460. FDA-2019-H-1623-0001Complaint
  461. FDA-2023-V-4229-0003Variance Approval from FDA CDRH to Elite Edge Productions
  462. FDA-2008-P-0309-0001Cancer Prevention Coalition - Citizen Petiton
  463. FDA-2005-P-0003-0007Appendix C [Sandoz Inc. Citizen Petition]
  464. FDA-2025-P-3263-0030Exhibit 28
  465. FDA-2014-N-0053-1313Reference 29 - FDA Guidance for Industry-The Seafood List July 2012 RE Requirements for…
  466. FDA-2019-N-5711-0023Ref. 20. DOJ 2017 Millions of Medicines Seized in Largest INTERPOL Operation Against…
  467. FDA-2023-H-0495-0001Complaint
  468. FDA-1984-G-0019-0007Supplement from NOVO Laboratories Inc. re Affirmation of GRAS Status of Certain Enzymes
  469. FDA-2008-D-0205-0059Reference 24 Q1E Evaluation of Stability Data re Chemistry, Manufacturing, and Control…
  470. FDA-2014-D-2275-0011Reference 10 CDC NHANES web page and 2011-2012 blood lead and body weight data re Lead in…
  471. FDA-2009-P-0102-0005Citizen Petition Approval Response Letter from FDA CDER to APP Pharmaceuticals LLC
  472. FDA-2016-P-3598-0005Final Response Letter from FDA to Axinn, Veltrop & Harkrider LLP
  473. FDA-2022-E-2185-0004Determination of Regulatory Review Period for Purposes of Patent Extension; Nextstellis
  474. FDA-2000-N-0044-0058FDA/HF-40 to Civil Justice Association of California
  475. FDA-2025-S-0024-01272025-000175 - Harmony Foods LLC. - Adult Fiber Advance Gummies 150ct- Supports digestive &…
  476. FDA-2025-H-1667-0001Complaint
  477. FDA-1978-N-1926-0002Classification of Dura Substitutes - Reference
  478. FDA-2025-P-1454-0007Completeness Assessment Correspondence from FDA CDER to Senores Pharmaceuticals, Inc.
  479. FDA-1982-P-0018-0047Background Material
  480. FDA-2019-V-4336-0001Variance Application from Mike Connolly
  481. FDA-2022-S-0024-11242022-001202 - TSI USA LLC- Tailored Script, Calcium hydroxyapatite- PROMOTES HEALTHY BONES
  482. FDA-2024-E-5424-0001Letter from U.S. Patent and Trademark Office to FDA CDER
  483. FDA-2005-P-0063-0014Tab 07 - Section V - Basis for Petition [FDA-2005-P-0063-0005]
  484. FDA-2015-P-2375-0004Acknowledgement Letter from FDA DDM to Public Citizen
  485. FDA-2023-N-3902-0764Comment from Lisa Pugh
  486. FDA-2024-V-0342-0001Variance Application from LEC Event Technology, Inc.
  487. FDA-2016-N-0124-0348Letter from FDA CDER to Lewis & Harrison
  488. FDA-2022-S-0024-04182022-000423 - Bayer HealthCare - One A Day Postnatal Complete Multivitamin - Supports…
  489. FDA-2011-N-0922-0547Reference 9. FRIA - AVMA U.S. Pet Ownership Statistics 2012 re Current Good Manufacturing…
  490. FDA-2019-V-3808-0002Acknowledgment Letter from FDA DMS to Clay Paky S. p. A.
  491. FDA-2010-S-0664-2206Perrigo - GoodSense Century Active Performance and Exchange Select Century Active…
  492. FDA-2022-S-0024-11562022-001219 - TSI USA LLC - Tailored Script, Alpha-Lipoic Acid - Supports the regulation…
  493. FDA-2019-D-0363-0001Cancer Clinical Trial Eligibility Criteria: Patients With Human Immunodeficiency Virus…
  494. FDA-1977-N-0018-0016Envelope re: Comment from the Honorable Congressman L. H. Fountain
  495. FDA-1987-N-0054-0207Certificate of Service re: Reinstated Motion of Warner-Lambert Company to Compel…
  496. FDA-2023-V-3009-0003Variance Approval Letter from FDA CDRH to William Collins
  497. FDA-2008-N-0163-0270Attachment Solving The Puzzle of Mystery Syndromes re Mary Davis, DAMS, Intl. - Comment…
  498. FDA-2014-P-1282-0005Suitability Petition AMENDMENT from Morgan Lewis & Bockius LLP
  499. FDA-2014-N-0189-83059Reference 155 Metal and Silicate Particles re Deeming Tobacco Products To Be Subject to…
  500. FDA-2014-N-0189-6232Request for Extension from Anonymous
  501. FDA-2000-D-0103-0003Guideline
  502. FDA-2021-D-0980-0002Assessing the Credibility of Computational Modeling and Simulation in Medical Device…
  503. FDA-2015-H-3811-0001CTP CMP Case re Wooldridge Investments, L.L.C. d/b/a Affiliated Foods of Manson
  504. FDA-2017-H-3813-0001CMP Complaint Issued to R.M. Roach and Sons Inc. d/b/a Rocs
  505. FDA-2019-S-0024-02752019002258 - ProCaps Laboratories - Maximum L + Z - Provide critical nutrients to our…
  506. FDA-2025-E-1478-0004Letter from U.S. Patent and Trademark Office to FDA CDER
  507. FDA-2018-N-4626-0086Nomination from Wedgewood Pharmacy
  508. FDA-2024-P-4159-0003Attachment 1
  509. FDA-2011-N-0922-0271Reference 1 - FSMA Supplemental Notice of Proposed Rulemaking for Current Good…
  510. FDA-1977-N-0002-1416Answer Letter from FDA to Comment from The Honorable Robert W. Kasten, Jr., United States…
  511. FDA-2016-H-0847-0002Complaint
  512. FDA-2014-E-0131-0008180 Day Letter from FDA CDER to the U.S. Patent and Trademark Office
  513. FDA-2017-P-3196-0036REFERENCES 33-63 COVER PAGE re Citizen Petition from Philip Spiller et. al.
  514. FDA-2013-P-1611-0001Citizen Petition from Clarissa Clarke
  515. FDA-1980-N-0049-0152Background Information re Biological Products; Bacterial Vaccines and Toxiods…
  516. FDA-2021-P-0437-0002Acknowledgment Letter from FDA DMS to Siri & Glimstad, LLP (on behalf of Informed Consent…
  517. FDA-2020-D-2016-0001Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol, Including…
  518. FDA-2019-E-5386-0006Letter from FDA CDER to U.S. Patent and Trademark Office
  519. FDA-1997-S-0039-2564Perrigo Company of South Carolina - Publix - advancedformula multivitamins - Essential…
  520. FDA-2017-H-6897-0001Complaint
  521. FDA-2025-P-2078-0007Completeness Assessment Correspondence from FDA CDER from Senores Pharmaceuticals, Inc.
  522. FDA-2020-V-1198-0001Variance Application from Rancho Merengue
  523. FDA-2013-S-0024-0259Perrigo Company (Smart sense - B12) - Letter
  524. FDA-2009-S-0607-0499Hillestad Pharmaceuticals USA, Inc. - Nite Caps - Restful Sleep - Relief of Occasional…
  525. FDA-2018-H-4423-0001Complaint
  526. FDA-2015-V-0427-0001Variance Application from Blue Steel Lighting Desing Inc.
  527. FDA-2012-S-1144-0269Xango, LLC - XANGO FAVAO Protein - Supports the body's natural calorie burning process
  528. FDA-2005-H-0506-0116TMJ Implants, Inc., and Robert W. Christensen and Maureen K Mooney - Reply to Motion 3
  529. FDA-1987-N-0010-0202Background Material
  530. FDA-1995-N-0063-0092Attachment D Proposed Discussion Points on Powdered Infant Comment from International…
  531. FDA-2009-N-0501-0012Agency Information Collection Activities; Submission for Office of Management and Budget…
  532. FDA-2007-P-0126-0005Background Material re Citizen Petition from Akorn -Strides, LLC - Attachment A- proposed…
  533. FDA-2019-H-0286-0001Complaint
  534. FDA-2018-S-0024-01612018001325- Jarrow Formulas, Inc.- Jarrow Formulas® Mineral Balance®- support and…
  535. FDA-2010-N-0174-0001Agency Information Collection Activities; Proposals, Submissions, and Approvals…
  536. FDA-2020-P-1768-0048Interim Response Letter from FDA CBER to Siri & Glimstad, LLP
  537. FDA-2007-D-0369-1324PSG_012249 - Draft Guidance on Chlordiazepoxide Hydrochloride
  538. FDA-2019-S-0024-03642019002354- International Vitamin Corporation -MULTIPLE CLAIMS (2)
  539. FDA-2021-V-0673-0002Acknowledgment Letter from FDA DMS to Aerolase
  540. FDA-1997-S-0039-0671Dee Cee Laboratories, Inc. - Letter
  541. FDA-2010-N-0004-0008Memorandum of Understanding: United States Food and Drug Administration and the Centers…
  542. FDA-2019-H-0302-0001Complaint
  543. FDA-2018-S-0023-0137NDI 1091 - Korean Red Ginseng Extract - Reference List
  544. FDA-2025-H-3220-0001Complaint
  545. FDA-2007-N-0376-0010FDA
  546. FDA-2010-S-0664-2176Perrigo - Target Up & Up Women's Multivitamin & Multimineral - Supports Breast and Bone…
  547. FDA-2009-P-0425-0007Gail Elbek - Supplement (re FDA-2009-P-0425-0001)
  548. FDA-2023-V-0289-0001Variance Application from Grae Hospitality LLC
  549. FDA-2010-S-0664-1040Country Life - TargetMins/Magnesium Caps w/Silica - Support Healthy Bone and Connective…
  550. FDA-2017-H-6914-0001Complaint
  551. FDA-2006-P-0282-0013Letter from FDA CDER to State of Vermont, State of Wisconsin, Statement of Minnesota…
  552. FDA-2020-V-0946-0001Variance Application for Michael J Calderaro LLC
  553. FDA-2019-S-0023-0009NDI 1107 - Triacylglycerol Lipase - Reference List
  554. FDA-2021-P-0338-0018Interim Response Letter from FDA CDER to Valisure, LLC
  555. FDA-2019-H-0485-0001Complaint
  556. FDA-2023-E-3230-0009Letter from FDA CDER to U.S. Patent and Trademark Office
  557. FDA-2012-D-1002-0019Questions and Answers Regarding Food Facility Registration (Seventh Edition); Guidance for…
  558. FDA-2012-S-1144-1777NBTY Inc - Women's Complete Multivitamin - Supports bone and breast health
  559. FDA-2022-E-2191-0004Letter from U.S. Patent and Trademark Office to FDA CDER
  560. FDA-2007-D-0150-0003Guidance for Industry Antibacterial Drug Products: Use of Noninferiority Studies to…
  561. FDA-2016-N-0832-0010Reference 9 FDA Memorandum dtd. Aug. 27, 1970 re Phibro Animal Health Corp.; Carbadox in…
  562. FDA-2017-H-6342-0001Complaint
  563. FDA-2025-H-0611-0001Complaint
  564. FDA-2010-S-0664-1041FoodScience Corporation - Orange Cream DHA with Vitamin D3 - Support Brain and Cognitive…
  565. FDA-1994-N-0036-0005HFZ-400 to Philips Medical Systems
  566. FDA-2013-N-1524-2007Nomination Letter Levothyroxine Sodium USP (T4) re: Comment from Fagron
  567. FDA-1997-S-0006-1364Courtesy Letter from CFSAN to USANA Health Sciences, Inc.
  568. FDA-2023-H-1462-0001Complaint
  569. FDA-2022-V-1557-0003Variance Approval from FDA CDRH to The Mockery Brand
  570. FDA-2006-N-0172-0064Novation - Testimony
  571. FDA-2017-E-3617-0002Letter from U.S. Patent and Trademark Office to CDER
  572. FDA-2016-H-1018-0001CTP CMP Case re 1888 Minimart Corp. d/b/a Victory Bagels Deli and Grocery
  573. FDA-2015-M-2739-0002Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval…
  574. FDA-2014-N-0189-7885Request for Extension from Anonymous
  575. FDA-1984-G-0174-0017List of Appendices: re Miles Laboratories, Inc. Petition for GRAS Affirmation of…
  576. FDA-1987-N-0010-0217Background Material
  577. FDA-2013-N-1619-0011Agency Information Collection Activities; Submission for Office of Management and Budget…
  578. FDA-2007-E-0338-0003Johnson & Johnson Consumer Companies, Inc. - Patent Term Extension Application
  579. FDA-2011-D-0652-0001Draft Guidances for Industry and Staff; Availability: 510(k) Program, Evaluating…
  580. FDA-2017-H-1233-0001CMP Complaint Issued to Wawa Florida, LLC d/b/a Wawa 5169
  581. FDA-2014-H-0146-0001Complaint
  582. FDA-2018-H-2035-0001Complaint
  583. FDA-2015-N-1514-0415Attachment 1 Survey Responses ID02 - ID201 re: Comment from Shiv Patel (Sai Shiva, LLC)…
  584. FDA-2016-H-4422-0001Complaint
  585. FDA-2017-H-6553-0001Complaint
  586. FDA-1996-P-0022-0007Citizen Petition Approval Response Letter from FDA CDER to KV Pharmaceutical Company
  587. FDA-2017-M-3430-0002Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval…
  588. FDA-2011-S-0932-2688NBTY, Inc. - Omega-3 Fish Oil - Heart Support
  589. FDA-2024-H-1954-0001Complaint
  590. FDA-2023-V-1835-0001Variance Application from Alexander & Tom, Inc.
  591. FDA-2020-D-1518-0017Development of Anti-Infective Drug Products for the Pediatric Population Guidance for…
  592. FDA-2010-S-0665-0085Agency Response Letter GRAS Notice No. GRN 000176 re NDI 643, Avovida: Phytosterols from…
  593. FDA-2011-S-0932-1138NBTY, Inc. (CVS Natural Cod Liver Oil Supplements)
  594. FDA-2022-N-0002-0040EAsN 141-450 approved December 23 2022
  595. FDA-2022-N-0150-0009Revocation of Two Authorizations of Emergency Use of In Vitro Diagnostic Device for…
  596. FDA-2007-N-0221-0001Request for Comments on the Science and Technology Report; Establishment of Docket…
  597. FDA-2014-N-0189-6828Request for Extension from Anonymous
  598. FDA-2019-E-5740-0001Letter from U S Patent and Trademark Office
  599. FDA-2014-N-0189-7329Request for Extension from Anonymous
  600. FDA-2025-V-2037-0003Variance Approval Letter from FDA CDRH to California Polytechnic State University
  601. FDA-2020-S-0024-08782020-001054 NOW Foods - Lucky Vitamin, Women's Herbal Support - Promote a healthy feminine…
  602. FDA-2021-P-1045-0002Acknowledgment Letter from FDA DMS to Siri and Glimstad LLP on behalf of Informed Consent…
  603. FDA-2024-H-0772-0001Complaint
  604. FDA-2018-H-0734-0001Complaint
  605. FDA-2013-S-0024-0507Highland Laboratories (Good Energy) - Letter
  606. FDA-2025-H-3756-0001Complaint
  607. FDA-2023-S-0024-08982023-002154 - Suppléments Aromatik Inc. - Land Art, L-THEANINE - promotes relaxation while…
  608. FDA-1985-G-0511-0005FDA/CFSAN and Novo Laboratories, Inc., October 28, 1996 - Memorandum of Telephone…
  609. FDA-1993-G-0218-0472Reference 31 - Del Monte Research Center, Walnut Creek, CA, Analysis for…
  610. FDA-2016-V-1204-0003Approval letter for FDA CDRH to AVERY DESIGN
  611. FDA-1980-P-0001-0002Citizen Petition from Surgical Appliance Industries, Inc.
  612. FDA-2000-D-0598-0011Draft Guidance for Industry; Availability: Studies to Evaluate the Safety of Residues of…
  613. FDA-2022-N-2390-0065Proposed Order
  614. FDA-2019-H-5601-0001Complaint
  615. FDA-2024-H-3039-0001Complaint
  616. FDA-2012-S-1144-1797OmNutrition, Inc. - Joint/Ligament Support - Helps Maintain Healthy Joint and Ligament…
  617. FDA-1977-N-0023-0004Reference 4 : RISC Group, "Risk of Myocardial Infarction and Death During Treatment with…
  618. FDA-2025-H-0064-0001Complaint
  619. FDA-2006-E-0380-0002FDA/CDER to the USPTO - Letter
  620. FDA-2016-F-1253-0468Environmental Defense Fund, et al.; Response to Objections and Requests for a Public…
  621. FDA-2014-N-1210-3454Reference 24-Sienaert, P., et al., A clinical review of the treatment of catatonia Re…
  622. FDA-2019-H-3503-0001Complaint
  623. FDA-2022-H-0857-0001Complaint
  624. FDA-2003-N-0436-0001Agency Information Collection Activities; Proposed Collection; Comment Request; Food…
  625. FDA-2023-N-3902-0308Comment from Wendy Vasquez
  626. FDA-2014-N-0189-5662Request for Extension from Anonymous
  627. FDA-2021-V-0796-0003Variance Approval Letter from FDA CDRH to Pierce Day
  628. FDA-2017-N-1003-0021Attachment 2 Site Visit Request re: Request for Participation (ELP) from Metronic
  629. FDA-2016-S-0024-1509Perrigo - careone® - Niacin - Energy Metabolism
  630. FDA-2018-H-1789-0001Complaint
  631. FDA-1984-N-0259-0367Certificate of Service
  632. FDA-2021-P-1125-0002Petition for Stay of Action from Vapornine, LLC dba New Leaf Vapor Company (VN)- Redacted
  633. FDA-2003-S-0732-0085NDI 149 - Pueraria mirifca - Original NDI Notification
  634. FDA-2019-H-2058-0001Complaint
  635. FDA-2008-N-0039-0016Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor; Ferric Oxide…
  636. FDA-2007-D-0136-0002Guidance for Industry; Pharmacogenomic Data Submissions — Companion Guidance; Draft…
  637. FDA-1976-N-0027-0027Background Information re Public Administrative File for Over-the-Counter Cold, Cough…
  638. FDA-2024-S-0024-13732024-002270 - DrVita Inc- Spring Valley Extra Strength Ashwagandha 1300mg 60ct- Stress…
  639. FDA-2011-S-0932-2176NOW Foods - Vegetarian Glucosamine 1000 - Supports Healthy Joint Function.
  640. FDA-2002-P-0247-0006Citizen Petition from Mission Possible International
  641. FDA-2017-H-3591-0001CMP Complaint Issued to Cholagh One, Inc. d/b/a River Rouge Liquor
  642. FDA-2018-E-3095-0004Letter from FDA CDER to U.S. Patent and Trademark Office
  643. FDA-2002-N-0233-0064List of attendees for 10/28th Conference in Portland, Oregon
  644. FDA-2013-S-0024-0540Bayer HealthCare - Phillips' Colon Health - Help support digestive health
  645. FDA-2005-V-0442-0006Prismatic Magic LLC - Application for Variance(2)
  646. FDA-2012-S-1144-2270Country Life, L. L. C. - Target-Mins/Magnesium Potassum Aspartate - Helps Relax Muscles
  647. FDA-2015-D-4599-0007Content of Human Factors Information in Medical Device Marketing Submissions; Draft…
  648. FDA-2019-D-1876-0005Reference 2 FDA Safety Communication Nov 2017 re Testing for Biotin Interference in In…
  649. FDA-2015-S-0024-3181Perrigo - Factory OTC®- promotional - Statins (cholesterol-lowering drugs) may reduce the…
  650. FDA-2012-D-0322-0035Ref 7b. FDA-and-EPAs-Response-to-External-Peer-Review-on-the-FDA-EPAs-Technical-Informatio…
  651. FDA-2019-N-1482-4329Sica, Matt. ANAB
  652. FDA-2004-P-0467-0031Reference 1: McNeil Nutrionals, "Petition to Amend the Regulation for 21 CFR Section101.80…
  653. FDA-2018-N-0180-0006Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic…
  654. FDA-2018-N-0417-0004Request for Nominations on the National Mammography Quality Assurance Advisory Committee
  655. FDA-2023-N-3902-0576Comment from Maura Fenlon
  656. FDA-2012-S-1144-0573Perrigo Company of South Carolina - DovaTM - Vitamin D - Supports Immune Function and Bone…
  657. FDA-2022-S-0024-00122021-001741 - SmartyPants Vitamins- SmartyPants Organics Men's Formula- Helps maintain…
  658. FDA-2014-N-0189-6200Request for Extension from Anonymous
  659. FDA-1978-N-0018-0048Letter from FDA/CDER to The Cosmetic, Toiletry and Fragrance Association
  660. FDA-2016-E-1298-0003Letter from FDA CDER to the U.S. Patent and Trademark Office
  661. FDA-1978-N-0018-0822Letter from King & Spalding on behalf of Givaudan-Roure Corporation to FDA CDER
  662. FDA-2022-P-0600-0004Interim Response from FDA CFSAN to Daniel Fabricant, Ph.D. on behalf of Natural Products…
  663. FDA-2025-H-6714-0001Complaint
  664. FDA-2024-H-5811-0001Complaint
  665. FDA-2014-N-0189-5709Request for Extension from Anonymous
  666. FDA-2025-V-6892-0001Variance Request from Totally Wired
  667. FDA-2015-S-0024-2041Perrigo - Smart Sense™ - Glucosamine Chondroitin Complex - helps support Bone Strength
  668. FDA-1995-P-0016-0255Background Material in 94P-0390
  669. FDA-2007-P-0346-0004Richard Sauerheber, Palomar College - Letter (2)
  670. FDA-2014-N-1210-3481Reference 51-Small, J.G., et al., Electroconvulsive treatment compared with lithium in the…
  671. FDA-2024-P-4667-0001Citizen Petition from Women’s Voices for the Earth
  672. FDA-2024-H-0495-0001Complaint
  673. FDA-2015-N-0101-1203Econ Reference 1 - Centers for Disease Control and Prevention re Safety and Effectiveness…
  674. FDA-2015-S-0024-3457Herbalife Int. od America - Relax Now dietary supplement - Help cope with occasional…
  675. FDA-1978-N-0023-0001Skin Bleaching Drug Products For Over-The-Counter Human Use Establishment Of A Monograph…
  676. FDA-2008-N-0574-0001Interim Safety and Risk Assessment of Melamine and Its Analogues in Food for Humans…
  677. FDA-2003-D-0377-0008FDA
  678. FDA-2012-V-0244-0001Special Occasions, LLC - Application for Variance
  679. FDA-2004-D-0248-0002GUIDANCE
  680. FDA-2021-N-0471-0366Reference 63 - FDA, “Lettuce: FDA Investigation Summary--Multistate Outbreak of E. coli…
  681. FDA-2018-N-4626-0969Nomination from Anivive Lifesciences, Inc
  682. FDA-2011-D-0618-0020Express Scripts, Inc. - Presentation
  683. FDA-1976-N-0027-0031Acknowledgement Letter from FDA/DDM to Fleming & Company
  684. FDA-2017-H-6247-0001Complaint
  685. FDA-2020-H-0221-0001Complaint
  686. FDA-2012-P-1107-0023Memorandum from FDA CDRH to DDM
  687. FDA-2023-F-2319-0004PHM Brands; Withdrawal of Food Additive Petition
  688. FDA-2024-H-0983-0001Complaint
  689. FDA-2017-H-5861-0001Complaint
  690. FDA-2007-N-0152-0049Solae, LLC (1)[FDA-2007-N-0152-0048.1] - Evidence-Based Review: Soy Protein & Coronary…
  691. FDA-2017-P-5978-0002Acknowledgement Letter from FDA DDM to JR Rapoza Associates Inc.
  692. FDA-2011-S-0932-0436Letter from NBTY, Inc.
  693. FDA-2025-H-0469-0001Complaint
  694. FDA-2016-H-2679-0001Complaint
  695. FDA-2023-P-0360-0191Response Letter from FDA CBER to Coalition Advocating for Adequately Labeled Medicines…
  696. FDA-2006-E-0440-0017U.S. Patent and Trademark Office to Pfizer Inc. - Letter
  697. FDA-2024-H-2306-0001Complaint
  698. FDA-2017-D-6580-2166Request for Extension from Consumer Healthcare Products Association (CHPA)
  699. FDA-2018-H-2227-0001Complaint
  700. FDA-2015-S-0024-3325Perrigo - Equate® - promotional - Vitamin A is essential for normal vision and plays a…
  701. FDA-2023-H-2463-0001Complaint
  702. FDA-2007-E-0105-0003FDA/CDER to the USPTO - Letter
  703. FDA-2016-M-2185-0002Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval…
  704. FDA-2014-N-0238-0073Attachment G Nov 1 2007 MA Dept of Early Ed and Care re Prank Incident Part 1 Comment from…
  705. FDA-2017-H-4727-0001CMP Complaint Issued to M and T Enterprises, Inc. d/b/a First Choice Market Hockinson…
  706. FDA-2017-N-6189-0004Reference 17_10 SG_How Tobacco Smoke Causes Disease The Biology and Behavioral Basis for…
  707. FDA-2018-H-2484-0001Complaint
  708. FDA-1979-N-0028-0011Memorandum of Telephone Conversation Dated January 10, 1997
  709. FDA-1984-G-0007-0205Background Material: E-4 Synopsis
  710. FDA-2017-H-3775-0001CMP Complaint Issued to Gary L. Rush d/b/a Rush’s Liquor Store
  711. FDA-2018-H-2636-0001Complaint
  712. FDA-1994-P-0041-0047BACKGROUND
  713. FDA-2007-D-0369-1249PSG_018869 - Draft Guidance on Nimodipine
  714. FDA-2009-S-0608-0126NDI 602 - Fernblock - SUPPORTING & RELATED MATERIALS
  715. FDA-2009-E-0231-0003FDA/CDER to the U.S. Patent and Trademark Office - Letter
  716. FDA-1997-S-0039-1655Life Force International - TruBoost -- TruBoost also contains potassium D-glucarate for…
  717. FDA-2015-H-3640-0001CTP CMP Case re ZRN, LLC d/b/a Hardy Shell 1
  718. FDA-2002-H-0065-0031GCF-1, Patton Boggs LLP and Onebane Firm
  719. FDA-2007-E-0105-0017Patent Term Extension Application - Exhibit F
  720. FDA-2017-H-2252-0001CMP Complaint Issued to Datta C-Store, LLC d/b/a Raceway 999
  721. FDA-2015-N-0101-1467Letter from FDA CDER to Bayer Corporation
  722. FDA-2020-V-0738-0002Acknowledgement Letter from FDA DMS to Circo Hermanos Vazquez
  723. FDA-1996-N-0028-0429Pure Encapsulations Inc, Durk Pearson, Sandy Shaw, Weider Nutrition International, Inc…
  724. FDA-2008-N-0397-0001Agency Information Collection Activities; Proposals, Submissions, and Approvals
  725. FDA-2017-S-0024-05542017000694 - International Vitamin Corporation - up&up Infant Vitamin D3 drops 400 IU…
  726. FDA-2019-V-3231-0003Letter from FDA CDRH to Michael's Mens Club
  727. FDA-2014-N-2244-0275Reference 267 University_of_Wisconsin-Madison_2014_Effect of Manure Treatment on Soil…
  728. FDA-2024-S-0024-11172024-001998 - A.T.P. Co. Ltd. - Beme WELLNESS Be Vitalized for Women (15- sachet) - Boost…
  729. FDA-1986-P-0053-0005Correction Letter from Quad Pharmaceuticals
  730. FDA-2020-N-2029-0171DP 6 2006-08-29 FDA Wesley
  731. FDA-2023-H-0145-0001Complaint
  732. FDA-2012-N-1093-0004Agency Information Collection Activities; Submission for Office of Management and Budget…
  733. FDA-1978-N-0018-0201FDA
  734. FDA-2015-S-0024-2324NBTY, Inc. - Fish Oil - Heart health
  735. FDA-2021-S-0024-07532021-001093 - Onnit- Onnit, Spirulina & Chlorella 80c- Supports detoxification
  736. FDA-1977-N-0014-0776Answer Letter from FDA to Comment from The Honorable Ray Roberts, United States House of…
  737. FDA-2016-H-3641-0001Complaint
  738. FDA-2017-E-6728-0007Letter from FDA CDER to U.S. Patent and Trademark Office
  739. FDA-2019-H-5029-0001Complaint
  740. FDA-2023-C-5679-0003Food Additive Petition (FAP) No. 4A4839 and Color Additive Petition (CAP) No. 4C0327…
  741. FDA-1992-N-0056-0002Notice of Proposed Rulemaking re Prescription Drug Marketing Act of 1987, Drug Amds of…
  742. FDA-2024-P-4512-0020Exhibit 17
  743. FDA-2017-V-1912-0002Acknowledgement Letter from FDA DDM to Starrlite
  744. FDA-2024-N-2886-0001Food and Drug Administration Information Technology Strategy and Customer Experience…
  745. FDA-2021-N-1309-0135Reference 132 BBDO Ethnic Marketing Opportunities 1975
  746. FDA-1997-S-0006-1206Response Letter from Pondera Pharmaceuticals, Inc. re Endorhinate PR
  747. FDA-2014-V-0642-0003Variance Approval from FDA CDRH to ATLANTA LASER AND LIGHT
  748. FDA-2005-N-0228-0003Supporting Statement
  749. FDA-2018-H-3213-0001Complaint
  750. FDA-1976-N-0525-0103HFC-2 to Honorable Christopher J. Dodd - Answer
  751. FDA-2024-E-0301-0002Patent Extension Application from McCarter & English, LLP (on behalf of Ogeda SA)
  752. FDA-2023-H-1317-0001Complaint
  753. FDA-2014-P-0646-0007Supplement from Kamat Pharmatech
  754. FDA-2005-N-0031-0001Agency Information Collection Activities: Proposed Collection; Comment Request; Importer's…
  755. FDA-2012-S-1144-1638NBTY, Inc. - TruLean - Lean Mass & Strength
  756. FDA-2018-D-1592-0005Agency Information Collection Activities; Announcement of Office of Management and Budget…
  757. FDA-2007-P-0056-0005FDA/CDER/ORP to Division of Dockets Management - Memorandum to Withdraw Citizen Petition
  758. FDA-2014-N-1051-0148146 7694105 Diary Subject R3019_Redacted
  759. FDA-2019-D-3592-0003Request for Extension from Advanced Medical Technology Association (AdvaMed)
  760. FDA-2019-P-2239-0002Acknowledgement Letter from FDA DDM to BioNeutra North America Inc
  761. FDA-2010-N-0621-0342FDA/OC (CDER) to the Presiding Officer, Center for Biologics Evaluation and Research (Dr…
  762. FDA-2015-S-0024-32384Life Research USA, LLC - Choice 50' - Superior blend of antioxidants
  763. FDA-2007-D-0369-1074PSG_214373 - Draft Guidance on Bexagliflozin
  764. FDA-2015-E-2602-0007Letter from FDA CDER to U.S. Patent and Trademark Office
  765. FDA-2015-S-0024-3250NOW Foods - Protocol for Life Balance® Ubiquinol, a dietary supplement - Cardiovascular…
  766. FDA-2023-H-0927-0001Complaint
  767. FDA-2018-D-0943-0011Elemental Impurities in Animal Drug Products—Questions and Answers; Guidance for Industry…
  768. FDA-2013-V-0231-0001Matilda Broadway Limited Partnership - Application for Variance
  769. FDA-2008-S-0664-0172NDI 543 - Conifer Green Needle Complex from Solagran Limited
  770. FDA-2018-S-0024-00172018-586 Pure Encapsulations - MULTIPLE CLAIMS (5)
  771. FDA-1999-F-2405-0001Food Irradiation Coalition c/o National Food Processors Association; Filing of Food…
  772. FDA-2001-D-0573-0006Guideline
  773. FDA-2016-H-0962-0001CTP CMP Case re Albertson's LLC d/b/a Albertson's 238
  774. FDA-2010-S-0664-0857EQUAVIE - EQUAIVE Weightless Legs - For Comfortable and Beautiful Legs
  775. FDA-2004-N-0318-0010CBER MDUFMA Activity
  776. FDA-2024-V-3731-0002Acknowledgment Letter from FDA DMS to MPE
  777. FDA-2011-D-0514-0002Industry and Staff; Procedures for Handling Section 522 Postmarket Surveillance Studies
  778. FDA-2011-S-0932-2316Auspicious Grooup, Inc., - UltruSil - Essential for Bone Maintenance, Joint Function, and…
  779. FDA-2021-S-0024-12032021-001527 - Reliance Vitamin Co. - Reliance Mood Formula 50 Billion Probiotic - Support…
  780. FDA-2015-H-4004-0001CTP CMP Case re Clays Market Place, Inc. d/b/a Clay’s Market
  781. FDA-2016-V-2550-0001Variance Application from Autumn Spontak
  782. FDA-2006-P-0089-0013Background Materials re: Citizen Petition from Custopharm, Inc- Attachment 2 - FDA…
  783. FDA-2020-E-2256-0002Patent Term Extension Application for BULKAMID® Patent No 7,780,958
  784. FDA-1985-C-0553-0002Canthaxanthin; Color Additive Exemtp From Ccertification - Notice of Confirmation of…
  785. FDA-1988-N-0061-0001Drug Export; Enlon® (Edrophonium Chloride Injection, USP)
  786. FDA-2015-S-0024-3303Perrigo - Walgreens Finest Nutrition - Calcium - Bone Health
  787. FDA-2014-N-0189-39440Request for Extension from Anonymous
  788. FDA-2022-E-2108-0007Letter from FDA CDER to U.S. Patent and Trademark Office
  789. FDA-2001-D-0254-0039Guidance for Industry: Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components…
  790. FDA-2021-P-0301-0001Citizen Petition from Adrienne Samuels
  791. FDA-2011-S-0932-1326NBTY, Inc. - DHEA - May Help Promote Sugar Metabolism
  792. FDA-2023-P-4877-0004Attachment 2 - RLD labeling-re: Suitability Petition from Pharmobedient Consulting
  793. FDA-2020-D-2024-0002Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain…
  794. FDA-2012-S-1144-0319NBTY Inc - Complete Daily - Complete Daily provides Beta-Carotene, Vitamin D and Vitamin C…
  795. FDA-2004-P-0214-0022References for Citizen Peition Response
  796. FDA-1980-N-0049-0130Background Information re Biological Products; Bacterial Vaccines and Toxiods…
  797. FDA-2016-H-0590-0001CTP CMP Case re Ameera Foodmart, Inc. d/b/a A and B Food Mart
  798. FDA-2018-H-2207-0001Complaint
  799. FDA-2023-V-2688-0003Variance Approval Letter from FDA CDRH to Chris Lilley
  800. FDA-2003-P-0273-0001Acknowledgement Letter to Covington & Burling [Aventis Pharmaceuticals, Inc.]
  801. FDA-2020-S-0024-0531SFC2020-000661 EuroPharma-Terry Naturally-EuroMedica- Terry Naturally, Heartburn Rescue…
  802. FDA-2015-S-0024-2239Perrigo - Berkley Jensen® - Women's Daily - Supports Bone & Heart Health
  803. FDA-2024-V-2017-0002Acknowledgment Letter from FDA DMS to The Hope Church
  804. FDA-2023-V-5064-0003Variance Approval Letter from FDA CDRH to Miami Country Day School
  805. FDA-2023-P-4876-0002Acknowledgement Letter from FDA DMS to Strides Pharma Inc.
  806. FDA-2023-E-2504-0001Letter from U. S. Patent and Trademark Office
  807. FDA-1990-N-0007-0204Background Material
  808. FDA-1993-G-0218-0361Section II of Reference 4 - United States Patent, No. 2,231,953, "Process for the…
  809. FDA-2023-N-2177-6887Reference 37 - “It Has Come to Our Attention” Letter to First Diagnostic Corp. re: ATFirst…
  810. FDA-2019-H-1705-0001Complaint
  811. FDA-2008-S-0664-0124NDI 467 - Conifer Green Needle Complex - Original NDI Notification
  812. FDA-2016-H-2231-0001Complaint
  813. FDA-2025-N-1928-0033GRAS Notice (GRN) 1278 - Lactiplantibacillus plantarum CGMCC 6312
  814. FDA-2022-H-2577-0001Complaint
  815. FDA-2015-N-0101-0490Reference 11-260 - FDA-1975-N-0012-0237 --- CP13…
  816. FDA-2011-V-0704-0002Acknowledgement Letter to Spring4th Center LLC
  817. FDA-2012-S-1144-0151NBTY, Inc. (Magnesium) - Letter
  818. FDA-2021-N-1333-0008Reference 8-Guidance for Hospitals, Nursing Homes, and Other Health Care Facilities FDA…
  819. FDA-2014-H-0591-0001Complaint
  820. FDA-2004-S-0571-0164NDI 230 - Sea Buckthorn Fruit Oil (resubmission) from Conseco Sea Buckthorn Co., Ltd
  821. FDA-2019-H-4893-0001Complaint
  822. FDA-2000-D-0186-0002Guidance for Industry and Food and Drug Administration Staff; Surveillance and Detention…
  823. FDA-2014-N-0189-82976Reference 71 The Health Consequences of Smoking-Chronic Obstructive Lung Disease re…
  824. FDA-2023-H-1915-0001Complaint
  825. FDA-2015-D-1211-0362Reference 1 REV. Epstein_et_al-2013-Transfusion re: Recommendations for Evaluating Donor…
  826. FDA-2025-P-3287-0040Appendix Vol35-3
  827. FDA-2025-S-0023-0034NDI 1387 - Phaeodactylum tricornutum extract powder from Microalgae Ask Us
  828. FDA-1981-N-0013-0011Oral Health Care Drug Products for Over-The-Counter Human Use; Proposed Amendment to the…
  829. FDA-2025-P-3956-0076Kästner N, Richter SH, Urbanik S, Kunert J, Waider J, Lesch KP, et al. Brain serotonin…
  830. FDA-2017-H-1671-0001CMP Complaint Issued to Kuifs Petroleum, L.P. d/b/a Shell / Checkout
  831. FDA-2010-S-0664-1055EuroPharma, Inc. - Adaptra - Maximize Energy
  832. FDA-2011-N-0747-0001Agency Information Collection Activities; Proposed Collection; Comment Request; Waiver of…
  833. FDA-2008-P-0329-0002Acknowledgement Letter to Osmotica Pharmaceutical Corp.
  834. FDA-2023-N-3902-0251Comment from Jonathan Linville
  835. FDA-2013-D-0147-0008Types of Communication During the Review of Medical Device Submissions; Guidance for…
  836. FDA-1997-S-0039-1785Perrigo Company of South Carolina - Vitasmart®- Vitamin B12 - Helps maintain a healthy…
  837. FDA-2004-P-0275-0017HF-22
  838. FDA-2011-N-0568-0004Agency Information Collection Activities; Proposals, Submissions, and Approvals…
  839. FDA-2014-N-0189-5886Request for Extension from Anonymous
  840. FDA-2022-S-0024-01332022-000107 - New Generation Wellness Inc. - Organic Prune & Senna Laxative Tablet…
  841. FDA-2015-P-3410-0004Response Letter from FDA CDER to Dr. David K. Cundiff
  842. FDA-2021-N-1309-0145Reference 142 Moran Ethnic and Socioeconomic Disparities 2019
  843. FDA-2020-D-1079-0002Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research…
  844. FDA-1984-N-0259-0027G-3.20 is now Exhibit G-3.20 re: Disclosure of Data and Information from Center for Drugs…
  845. FDA-2003-N-0388-0025Attachment - "Bibliography Listing by Author" - [American Dental Association (ADA)…
  846. FDA-2011-D-0889-0157Guidance for Industry; New Animal Drugs and New Animal Drug Combination Products…
  847. FDA-2011-N-0017-0001Agency Information Collection Activities; Proposals, Submissions, and Approvals: Voluntary…
  848. FDA-2024-H-0182-0001Complaint
  849. FDA-2016-P-2955-0031Comment from Nicholas Isel
  850. FDA-2017-V-1457-0001Variance Application from Saucerful of Secrets, LLC
  851. FDA-2019-H-5379-0001Complaint
  852. FDA-2014-N-1051-0040038 16.1.6-listing-of-subjects
  853. FDA-2016-S-0024-0933Nanotech Health Inc - Nanoxyn Alpha - Boost cellular energy production
  854. FDA-2016-S-0024-1796NBTY - Vitamin C supplements under the ShopRite label - Supports immune system health
  855. FDA-2003-Q-0292-0031Tab 5 " N-3 Polyunsaturated Fatty Acids in Coronary Heart Disease " - Reference to ANS1
  856. FDA-2004-D-0498-0004Pharmacokinetics in Pregnancy -- Study Design, Data Analysis, and Impact on Dosing and…
  857. FDA-1993-G-0218-0418Response Letter from Canadian Harvest, U. S. A., L. P. to FDA CFSAN
  858. FDA-2010-S-0664-2326Perrigo - H-E-B Senior Complete - Energy Metabolism
  859. FDA-2014-N-1112-0001Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of…
  860. FDA-2024-V-5132-0002Acknowledgment Letter from FDA DMB to Jacob Lindell
  861. FDA-2000-D-0130-0033HFC-240 & Werum Software & Systems AG 10/6/01 - Memorandum of Meeting
  862. FDA-2013-N-1662-0001Medical Devices; Immunology and Microbiology Devices; Classification of John Cunningham…
  863. FDA-2014-N-0189-5619Request for Extension from Taz Dougherty
  864. FDA-2015-N-0045-0060Letter from Arnold & Porter LLP, (OAPI) re Denial of Request for Extension
  865. FDA-2007-P-0006-0003Matrix Laboratories, Inc. - Attachment 1 - Proprietary NameSearch Results from "OB_Rx" on…
  866. FDA-2009-N-0143-1116See FDA-2009-N-0143-1017
  867. FDA-2021-S-0024-09592021-001269 - EuroPharmaTerry NaturallyEuroMedica - Terry Naturally, Melatonin 5 MG Berry…
  868. FDA-2014-N-0189-3232Request for Extension from Anonymous
  869. FDA-2025-P-5739-0003Attachment 1
  870. FDA-2023-N-2177-6891Reference 41 - Untitled Letter to Interleukin Genetics, Inc.
  871. FDA-2017-V-6088-0001Variance Application from King Dahl Event Design
  872. FDA-1996-N-0028-0153Pre_FDMS - OMB Review 10/25/2005
  873. FDA-2017-H-3451-0001CMP Complaint Issued to George Freeman and Earnestine Freeman d/b/a Han-D-Sak
  874. FDA-2000-V-1073-0002Acknowledgement Letter to B.E. Meyers & Company, Inc.
  875. FDA-2011-S-0932-2020NBTY, Inc. - Co Q10 - Heart Health
  876. FDA-2019-H-1803-0001Complaint
  877. FDA-2007-D-0369-0833PSG_018027 - Draft Guidance on Lithium Carbonate Tablet, extended release; Oral
  878. FDA-2014-N-0440-0001Microbiology Devices; Reclassification of Influenza Virus Antigen Detection Test Systems…
  879. FDA-2016-V-2653-0002Acknowledgement Letter from FDA DDM to Ulrich Buddemeier
  880. FDA-2019-H-4316-0001Complaint
  881. FDA-2016-S-0023-0065NDI 923 - Sea buckthorn seed oil - Original NDI Notification
  882. FDA-2018-S-0024-03102018-2208 HealthGenesis- MULTIPLE CLAIMS (8)
  883. FDA-1980-N-0038-0386Certificate of Service re: Joint Motion for Admission into Evidence Documents and Written…
  884. FDA-2014-N-0001-0057Food Advisory Committee; Notice of Meeting
  885. FDA-2023-N-3902-1640Comment from Joan Christopher
  886. FDA-2022-H-1071-0001Complaint
  887. FDA-2021-M-0676-0002Medical Devices: Safety and Effectiveness Summaries for Premarket Approval Applications
  888. FDA-2016-D-2335-1712Agency Information Collection Activities; Announcement of Office of Management and Budget…
  889. FDA-2011-S-0932-1914General Nutrition Corporation - Multiple claims - 28
  890. FDA-2014-P-1773-0002Acknowledgement Letter From FDA DDM to Pharmacits Planning Sercive Inc. (PPSI)
  891. FDA-2022-P-0200-0002Acknowledgment Letter from FDA DMS to Lachman Consultants Inc.
  892. FDA-1995-P-0281-0024Letter from Patton Boggs, L.L.P. (National Yogurt Association) to FDA CFSAN
  893. FDA-1976-N-0523-0001Notice of Availability of Draft Regulations Concerning Good Manufacturing Practices
  894. FDA-2022-N-3239-0001Medical Devices; Orthopedic Devices; Classification of the Implantable Post- Surgical…
  895. FDA-2016-H-1014-0002Complaint
  896. FDA-2017-H-3569-0001CMP Complaint Issued to Richie’s Too, Inc. d/b/a Richie’s Too
  897. FDA-1991-N-0014-0015FDA
  898. FDA-2025-H-7403-0001Complaint
  899. FDA-2021-S-0024-11762021-001492 - Hylands- Hyland's Naturals Organic Elderberry Plus- support immune health
  900. FDA-2019-E-5271-0005Determination of Regulatory Review Period for Purposes of Patent Extension; BARRICAID…
  901. FDA-2023-N-0155-0046Agency Information Collection Activities; Submission for Office of Management and Budget…
  902. FDA-2015-S-0024-1586NBTY - Quick Dissolve Melatonin supplements under the H-E-B - Helps promote relaxation and…
  903. FDA-2016-S-0024-1799NBTY - B-Complex 50 supplements - Supports energy metabolism
  904. FDA-2019-H-0965-0001Complaint
  905. FDA-2020-H-0295-0001Complaint
  906. FDA-2018-N-0981-0001Preparation for International Cooperation on Cosmetics Regulation Twelfth Annual Meeting…
  907. FDA-2023-H-0511-0001Complaint
  908. FDA-2002-D-0268-0004Draft Guidance Document re Pharmacovigilance of Veterinary Medicinal Products Controlled…
  909. FDA-2010-S-0664-159821st Century HealthCare, Inc. - Niacinamide Prolonged Release Tablets - Convert Food into…
  910. FDA-2005-V-0452-0004FDA Response to Night Vision Equipment Company for Approval for Variance - Letter
  911. FDA-2010-D-0164-0002Guidance for Industry; Studies to Evaluate the Metabolism and Residue Kinetics of…
  912. FDA-2015-S-0024-2147NBTY, Inc. - Biotin - Supports healthy hair, skin and nails
  913. FDA-1997-S-0039-1881Enzymatic Therapy, Inc. - PredictEase and Predict IB - A combination of probiotics, fiber…
  914. FDA-2014-H-1954-0001Complaint
  915. FDA-2022-S-0024-04002022-000406 - Atrium Innovations - Pure Encapsulations, Choline (bitartrate) - Supports…
  916. FDA-2026-H-0050-0001Complaint
  917. FDA-2003-P-0174-0005FDA - Proposed Rule - Pre-Pub
  918. FDA-2020-P-2289-0004Interim response to Loeb & Loeb, LLP from FDA CDRH
  919. FDA-2006-N-0250-0001Agency Information Collection Activities; Submission for Office of Management and Budget…
  920. FDA-2019-D-3805-0002The Accreditation Scheme for Conformity Assessment Pilot Program; Draft Guidance for…
  921. FDA-2020-D-1794-0010Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study…
  922. FDA-2016-H-3805-0001Complaint
  923. FDA-2008-P-0080-0004Acknowledgement Letter to Lupin Pharmaceuticals, Inc. - [FDA-2008-P-0080-0002]
  924. FDA-1992-N-0005-0006Memorandum of Telephone Conversation Between FDA to John Buonora on Behalf of Susan M…
  925. FDA-1997-S-0039-2192Perrigo - HEALTHsense - One Daily - Calcium & Vitamin D to promote strong bones & breast…
  926. FDA-2018-P-3730-0004Attachment 2 Drugs @ FDA re: Citizen Petition from Aizant Drug Research Solutions Pvt. Ltd
  927. FDA-2020-M-2094-0001Premarket Approval for BP180279, Avioq, Inc, VioOne™ HIV Profile™ Supplemental Assay
  928. FDA-2015-H-4037-0001CTP CMP Case re CSG Management Corp. d/b/a CSG Food Mart / Sunoco
  929. FDA-2015-H-4812-0001CTP CMP Case re Maynards Food Center of Westbrook Inc. d/b/a Maynard’s of Akron
  930. FDA-2024-P-0425-0006Amended Suitability Petition from RegCon Solutions, LLC
  931. FDA-2025-H-3329-0001Complaint
  932. FDA-1977-N-0019-0065Answer Letter from FDA to Comment from The Honorable John D. Dingell, U. S. House of…
  933. FDA-2023-H-4861-0001Complaint
  934. FDA-2014-N-0189-9781Request for Extension from Anonymous
  935. FDA-2023-N-3902-1445Comment from Jennifer Grace
  936. FDA-2014-N-2244-0002List of Referencesre Draft Environmental Impact Statement for the Proposed Rule, Standards…
  937. FDA-2019-N-5959-0018Reference 15 - National Association of Chain Drug Stores - Citizen Petition Requesting FDA…
  938. FDA-2005-E-0188-0007FDA/CDER to the U.S. Patent and Trademark Office
  939. FDA-1980-N-0038-0419Certificate of Service re: Written Direct Testimony of Howard I. Maibach, M.D. for…
  940. FDA-2015-H-1138-0001Complaint
  941. FDA-2016-D-0734-0012Evaluation and Reporting of Age-, Race-, and Ethnicity-Specific Data in Medical Device…
  942. FDA-1994-F-0434-0002Atlantis Corp.; Filing of Food Additive Petition
  943. FDA-2016-H-3860-0001Complaint
  944. FDA-2013-N-1524-2155Nomination Letter Pyridoxine Hydrochloride USP (Vitamin B6 HCl) re: Comment from Fagron
  945. FDA-2015-V-1554-0001Variance Application from Jonathan Wilson
  946. FDA-2003-D-0186-0002Guidance
  947. FDA-2004-N-0202-0001Medicare Prescription Drug, Improvement, and Modernization Act of 2003; Study on Making…
  948. FDA-2017-P-4575-0184Reference 177 - Beneficial nutritional properties of olive oil - implications for…
  949. FDA-2007-D-0369-1348PSG_016769 - Draft Guidance on Flavoxate Hydrochloride
  950. FDA-2015-H-4606-0001CTP CMP Case re Tejspann LLC d/b/a Superway Food Mart
  951. FDA-2011-D-0893-0001Draft Guidances for Industry and Staff; Availability: Center for Devices and Radiological…
  952. FDA-2022-P-1049-0001Suitability Citizen Petition from Noble Pharma LLC
  953. FDA-2017-P-6028-0001Citizen Petition from Axinn, Veltrop & Harkrider LLP
  954. FDA-2019-H-5384-0001Complaint
  955. FDA-2015-S-0024-1534Nutrition Express - Lindberg® Sunflower E 400 IU - For Heart, Skin and Cellular Health
  956. FDA-2016-E-1265-0004Letter from U.S. Patent and Trademark Office
  957. FDA-2024-E-0218-0010Letter from FDA CDER to U.S. Patent and Trademark Office
  958. FDA-2015-N-2523-0001Intent To Review a Study Data Reviewer’s Guide Template
  959. FDA-2023-D-1716-0058Registration and Listing of Cosmetic Product Facilities and Products; Guidance for…
  960. FDA-2017-H-5303-0001Complaint
  961. FDA-2019-S-0024-05862019-2610 Futurebiotics LLC - MULTIPLE CLAIMS (2)
  962. FDA-2009-E-0206-0007FDA/CDER to U.S. Patent and Trademark Office - Letter
  963. FDA-2018-S-0024-0658Solvotrin Therapeutics- Active Iron High Potency- supports the formation of haemoglobin…
  964. FDA-2024-V-4468-0002Acknowledgment Letter from FDA DMS to EOTECH, LLC
  965. FDA-2020-V-2026-0003Letter from FDA CDRH to Darry Kurpisz
  966. FDA-1999-N-0134-0090Risk Assessment
  967. FDA-2016-S-0024-1418Perrigo Company - Shopko®- CENTURY - Immune Support
  968. FDA-2006-E-0200-0002U.S. Patent and Trademark Office to Mark D. Passler
  969. FDA-2023-H-0833-0001Complaint
  970. FDA-1987-N-0010-0259Background Material
  971. FDA-2013-H-1335-0001Complaint
  972. FDA-2021-S-0024-13922021-2636 Rightful LLC - MULTIPLE CLAIMS (5)
  973. FDA-2002-P-0046-0003Citizen Petition from Arla Foods Ingredients amba (Hyman, Phelps & McNamara, PC)
  974. FDA-2016-H-3262-0001Complaint
  975. FDA-2022-H-3397-0001Complaint
  976. FDA-2012-P-1107-0033Oxiplex®/SP Gel; FzioMed, Incorporated’s Petition for Review of the Food and Drug…
  977. FDA-2006-E-0195-0001U.S. Patent and Trademark Office
  978. FDA-2015-N-0101-0610Reference 12-49 - FDA-1975-N-0012-0115 --- C42 Kao Corp of America 1-17-1996 re Safety and…
  979. FDA-1976-N-0476-0593Letter from Jean M. Taylor to Samuel I. Shibko
  980. FDA-2019-H-0872-0001Complaint
  981. FDA-2010-D-0645-0003Guidance for Industry and Staff - Class II Special Controls Guidance Document: Contact…
  982. FDA-2015-H-1067-0001Complaint
  983. FDA-2023-N-2177-6883Reference 33 - FDA, “Policy for Coronavirus Disease-2019 Tests (Revised); Guidance for…
  984. FDA-1983-M-0010-0042FDA/Office of Health Affairs to Rainer-Sadler, M.D., P.C.
  985. FDA-2015-S-0024-3058Bluebonnet Nutrition Corporation - Cellular Active® Coenzyme B-Complex Capsules - This…
  986. FDA-2024-S-0024-04422024-001260 - Kaged - KAGED, Pre-Workout Sport- PROMOTES FOCUS
  987. FDA-1991-P-0355-0014Tab I Section 6 Potential Problems w/Ultrapasteurized Egg Product; Recommendations and…
  988. FDA-2015-N-0030-8454Final Standard MOU Addressing Certain Distributions of Compounded Human Drug Products…
  989. FDA-1998-N-0575-0002Agency Information Collection Activities; Announcement of OMB Approval; Guidance for…
  990. FDA-2020-E-1588-0003Patent Term Extension letter from FDA CDER to The Honorable Andrei Lancu
  991. FDA-2016-N-3118-0376256_FAERS
  992. FDA-2016-H-0108-0001CTP CMP Case re Pilot Travel Centers LLC d/b/a Pilot Travel Centers 096
  993. FDA-2020-P-1510-0007Appendix #9 “Over-the-Counter Drug Review,” 21 CFR part 330.1 RE: Citizen's Petition from…
  994. FDA-2009-D-0542-0016Guidance for Industry: Distinguishing Liquid Dietary Supplements From Beverages
  995. FDA-2007-E-0102-0016U.S. Patent and Trademark Office to Sidley Austin LLP - Notice of Final Determination and…
  996. FDA-2024-N-5471-0561Reference 559 Cornelius Trends in cigarette pricing and 2015
  997. FDA-2020-V-1890-0001Variance Application from Jacob Berg Potter
  998. FDA-2018-P-0998-0003Determination That PROLIXIN (Fluphenazine Hydrochloride) Tablets, 1 Milligram, 2.5…
  999. FDA-2010-S-0664-2235Perrigo - Walgreens A thru Z Select - Bone Health
  1000. FDA-2015-H-0130-0001Complaint

About this dataset

Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.

Source: Regulations.gov (U.S. General Services Administration eRulemaking Program)